000006223412-262024Q3falseP5DP5D0.09080380.0943588xbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:puremcs:agreementmcs:tranchemcs:hotel00000622342023-12-292024-09-260000062234us-gaap:CommonStockMember2024-10-290000062234us-gaap:CommonClassBMember2024-10-2900000622342024-09-2600000622342023-12-280000062234us-gaap:CommonStockMember2023-12-280000062234us-gaap:CommonStockMember2024-09-260000062234us-gaap:CommonClassBMember2024-09-260000062234us-gaap:CommonClassBMember2023-12-280000062234us-gaap:AdmissionMember2024-06-282024-09-260000062234us-gaap:AdmissionMember2023-06-302023-09-280000062234us-gaap:AdmissionMember2023-12-292024-09-260000062234us-gaap:AdmissionMember2022-12-302023-09-280000062234us-gaap:OccupancyMember2024-06-282024-09-260000062234us-gaap:OccupancyMember2023-06-302023-09-280000062234us-gaap:OccupancyMember2023-12-292024-09-260000062234us-gaap:OccupancyMember2022-12-302023-09-280000062234us-gaap:ConcessionsMember2024-06-282024-09-260000062234us-gaap:ConcessionsMember2023-06-302023-09-280000062234us-gaap:ConcessionsMember2023-12-292024-09-260000062234us-gaap:ConcessionsMember2022-12-302023-09-280000062234us-gaap:FoodAndBeverageMember2024-06-282024-09-260000062234us-gaap:FoodAndBeverageMember2023-06-302023-09-280000062234us-gaap:FoodAndBeverageMember2023-12-292024-09-260000062234us-gaap:FoodAndBeverageMember2022-12-302023-09-280000062234us-gaap:ProductAndServiceOtherMember2024-06-282024-09-260000062234us-gaap:ProductAndServiceOtherMember2023-06-302023-09-280000062234us-gaap:ProductAndServiceOtherMember2023-12-292024-09-260000062234us-gaap:ProductAndServiceOtherMember2022-12-302023-09-2800000622342024-06-282024-09-2600000622342023-06-302023-09-2800000622342022-12-302023-09-280000062234mcs:TheatreOperationsMember2024-06-282024-09-260000062234mcs:TheatreOperationsMember2023-06-302023-09-280000062234mcs:TheatreOperationsMember2023-12-292024-09-260000062234mcs:TheatreOperationsMember2022-12-302023-09-280000062234us-gaap:CommonStockMember2024-06-282024-09-260000062234us-gaap:CommonStockMember2023-06-302023-09-280000062234us-gaap:CommonStockMember2023-12-292024-09-260000062234us-gaap:CommonStockMember2022-12-302023-09-280000062234us-gaap:CommonClassBMember2024-06-282024-09-260000062234us-gaap:CommonClassBMember2023-06-302023-09-280000062234us-gaap:CommonClassBMember2023-12-292024-09-260000062234us-gaap:CommonClassBMember2022-12-302023-09-2800000622342022-12-2900000622342023-09-280000062234us-gaap:FairValueInputsLevel3Member2023-12-292024-06-270000062234us-gaap:FairValueInputsLevel3Member2024-06-270000062234us-gaap:FairValueInputsLevel3Member2023-06-302023-09-280000062234us-gaap:FairValueInputsLevel3Member2023-09-280000062234us-gaap:EmployeeStockOptionMember2024-06-282024-09-260000062234us-gaap:EmployeeStockOptionMember2023-06-302023-09-280000062234us-gaap:EmployeeStockOptionMember2023-12-292024-09-260000062234us-gaap:EmployeeStockOptionMember2022-12-302023-09-280000062234us-gaap:RestrictedStockUnitsRSUMember2024-06-282024-09-260000062234us-gaap:RestrictedStockUnitsRSUMember2023-06-302023-09-280000062234us-gaap:RestrictedStockUnitsRSUMember2023-12-292024-09-260000062234us-gaap:RestrictedStockUnitsRSUMember2022-12-302023-09-280000062234us-gaap:PerformanceSharesMember2024-06-282024-09-260000062234us-gaap:PerformanceSharesMember2023-06-302023-09-280000062234us-gaap:PerformanceSharesMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMember2022-12-302023-09-280000062234mcs:ConvertibleSeniorNotesMember2024-06-282024-09-260000062234mcs:ConvertibleSeniorNotesMember2023-06-302023-09-280000062234mcs:ConvertibleSeniorNotesMember2023-12-292024-09-260000062234mcs:ConvertibleSeniorNotesMember2022-12-302023-09-280000062234us-gaap:CommonStockMember2023-12-280000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-12-280000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-12-280000062234us-gaap:RetainedEarningsMember2023-12-280000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-280000062234us-gaap:TreasuryStockCommonMember2023-12-280000062234us-gaap:ParentMember2023-12-280000062234us-gaap:CommonClassBMember2023-12-292024-03-280000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2023-12-292024-03-280000062234us-gaap:CommonStockMember2023-12-292024-03-280000062234us-gaap:RetainedEarningsMember2023-12-292024-03-2800000622342023-12-292024-03-280000062234us-gaap:TreasuryStockCommonMember2023-12-292024-03-280000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-12-292024-03-280000062234us-gaap:CommonStockMember2023-12-292024-03-280000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-12-292024-03-280000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-292024-03-280000062234us-gaap:CommonStockMember2024-03-280000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-03-280000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-03-280000062234us-gaap:RetainedEarningsMember2024-03-280000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-280000062234us-gaap:TreasuryStockCommonMember2024-03-280000062234us-gaap:ParentMember2024-03-280000062234us-gaap:CommonClassBMember2024-03-292024-06-270000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2024-03-292024-06-270000062234us-gaap:CommonStockMember2024-03-292024-06-270000062234us-gaap:RetainedEarningsMember2024-03-292024-06-2700000622342024-03-292024-06-270000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-03-292024-06-270000062234us-gaap:TreasuryStockCommonMember2024-03-292024-06-270000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-292024-06-270000062234us-gaap:CommonStockMember2024-06-270000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-06-270000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-270000062234us-gaap:RetainedEarningsMember2024-06-270000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-270000062234us-gaap:TreasuryStockCommonMember2024-06-270000062234us-gaap:ParentMember2024-06-270000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2024-06-282024-09-260000062234us-gaap:RetainedEarningsMember2024-06-282024-09-260000062234us-gaap:TreasuryStockCommonMember2024-06-282024-09-260000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-282024-09-260000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-282024-09-260000062234us-gaap:CommonStockMember2024-09-260000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2024-09-260000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-260000062234us-gaap:RetainedEarningsMember2024-09-260000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-260000062234us-gaap:TreasuryStockCommonMember2024-09-260000062234us-gaap:ParentMember2024-09-260000062234us-gaap:CommonStockMember2022-12-290000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-290000062234us-gaap:RetainedEarningsMember2022-12-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-290000062234us-gaap:TreasuryStockCommonMember2022-12-290000062234us-gaap:ParentMember2022-12-290000062234us-gaap:NoncontrollingInterestMember2022-12-290000062234us-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2022-12-302023-03-300000062234us-gaap:RetainedEarningsMember2022-12-302023-03-300000062234us-gaap:ParentMember2022-12-302023-03-3000000622342022-12-302023-03-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2022-12-302023-03-300000062234us-gaap:TreasuryStockCommonMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2022-12-302023-03-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2022-12-302023-03-300000062234us-gaap:NoncontrollingInterestMember2022-12-302023-03-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-302023-03-300000062234us-gaap:CommonStockMember2023-03-300000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-03-300000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-300000062234us-gaap:RetainedEarningsMember2023-03-300000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-300000062234us-gaap:TreasuryStockCommonMember2023-03-300000062234us-gaap:ParentMember2023-03-300000062234us-gaap:NoncontrollingInterestMember2023-03-3000000622342023-03-300000062234us-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2023-03-312023-06-290000062234us-gaap:CommonStockMember2023-03-312023-06-290000062234us-gaap:RetainedEarningsMember2023-03-312023-06-290000062234us-gaap:ParentMember2023-03-312023-06-2900000622342023-03-312023-06-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-03-312023-06-290000062234us-gaap:TreasuryStockCommonMember2023-03-312023-06-290000062234us-gaap:NoncontrollingInterestMember2023-03-312023-06-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-312023-06-290000062234us-gaap:CommonStockMember2023-06-290000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-06-290000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-290000062234us-gaap:RetainedEarningsMember2023-06-290000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-290000062234us-gaap:TreasuryStockCommonMember2023-06-290000062234us-gaap:ParentMember2023-06-290000062234us-gaap:NoncontrollingInterestMember2023-06-2900000622342023-06-290000062234us-gaap:RetainedEarningsMemberus-gaap:CommonClassBMember2023-06-302023-09-280000062234us-gaap:ParentMemberus-gaap:CommonClassBMember2023-06-302023-09-280000062234us-gaap:RetainedEarningsMember2023-06-302023-09-280000062234us-gaap:ParentMember2023-06-302023-09-280000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-302023-09-280000062234us-gaap:TreasuryStockCommonMember2023-06-302023-09-280000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-302023-09-280000062234us-gaap:CommonStockMember2023-09-280000062234us-gaap:CommonStockMemberus-gaap:CommonClassBMember2023-09-280000062234us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-09-280000062234us-gaap:RetainedEarningsMember2023-09-280000062234us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-280000062234us-gaap:TreasuryStockCommonMember2023-09-280000062234us-gaap:ParentMember2023-09-280000062234us-gaap:NoncontrollingInterestMember2023-09-280000062234us-gaap:FairValueInputsLevel1Member2024-09-260000062234us-gaap:FairValueInputsLevel1Member2023-12-280000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2024-09-260000062234us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member2023-12-280000062234us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-280000062234us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-260000062234us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-260000062234us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2023-12-280000062234us-gaap:FairValueInputsLevel2Member2024-09-260000062234us-gaap:FairValueInputsLevel2Memberus-gaap:ConvertibleDebtMember2024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:AdmissionMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:OccupancyMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:ConcessionsMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:FoodAndBeverageMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2024-06-282024-09-260000062234us-gaap:CorporateNonSegmentMember2024-06-282024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:AdmissionMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:OccupancyMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:ConcessionsMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:FoodAndBeverageMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2023-12-292024-09-260000062234us-gaap:CorporateNonSegmentMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:AdmissionMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:OccupancyMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:ConcessionsMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:FoodAndBeverageMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2023-06-302023-09-280000062234us-gaap:CorporateNonSegmentMember2023-06-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:AdmissionMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:AdmissionMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:OccupancyMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:OccupancyMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ConcessionsMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:ConcessionsMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:FoodAndBeverageMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:FoodAndBeverageMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMemberus-gaap:ProductAndServiceOtherMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMemberus-gaap:ProductAndServiceOtherMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMembermcs:TheatresMember2022-12-302023-09-280000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2022-12-302023-09-280000062234us-gaap:CorporateNonSegmentMember2022-12-302023-09-280000062234mcs:AdvancedSaleOfTicketsMember2024-09-260000062234us-gaap:OperatingSegmentsMembermcs:TheatresSegmentMember2024-09-260000062234mcs:AdvancedSaleOfTicketsMember2023-12-292024-09-260000062234us-gaap:OperatingSegmentsMembermcs:HotelsResortsMember2024-09-2600000622342022-12-302023-12-280000062234us-gaap:RevolvingCreditFacilityMember2023-10-160000062234us-gaap:RevolvingCreditFacilityMember2024-09-260000062234us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-10-162024-09-260000062234us-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-09-260000062234mcs:GreaterOfFederalFundsRateOrOvernightBankFundingRateMemberus-gaap:RevolvingCreditFacilityMember2023-10-162024-09-260000062234mcs:BasedUponNetLeverageRatioMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2023-10-162024-09-260000062234mcs:BasedUponNetLeverageRatioMemberus-gaap:RevolvingCreditFacilityMembermcs:OneMonthSecuredOvernightFinancingRateSOFRMember2023-10-162024-09-260000062234mcs:BasedUponNetLeverageRatioMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2024-09-260000062234srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2023-10-162024-09-260000062234srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2023-10-162024-09-260000062234us-gaap:RevolvingCreditFacilityMember2023-10-162024-09-260000062234mcs:ForFullFiscalQuarterIfMaterialAcquisitionIsConsummatedMemberus-gaap:RevolvingCreditFacilityMember2023-10-162024-09-260000062234mcs:NotePurchaseAgreementMember2024-09-260000062234srt:MinimumMembermcs:NotePurchaseAgreementMember2024-09-260000062234srt:MaximumMembermcs:NotePurchaseAgreementMember2024-09-260000062234us-gaap:SeniorNotesMember2024-09-260000062234us-gaap:SeniorNotesMember2024-07-090000062234us-gaap:SeniorNotesMember2024-07-092024-07-090000062234mcs:SixPointEightNinePercentSeries2024SeniorNotesTrancheAMemberus-gaap:SeniorNotesMember2024-07-090000062234mcs:SixPointEightNinePercentSeries2024SeniorNotesTrancheAMemberus-gaap:SeniorNotesMember2024-07-092024-07-090000062234mcs:SevenPintZeroTwoPercentSeries2024SeniorNotesTrancheBMemberus-gaap:SeniorNotesMember2024-07-090000062234mcs:SevenPintZeroTwoPercentSeries2024SeniorNotesTrancheBMemberus-gaap:SeniorNotesMember2024-07-092024-07-090000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-09-260000062234us-gaap:ConvertibleDebtMember2020-09-170000062234us-gaap:ConvertibleDebtMember2020-09-220000062234us-gaap:ConvertibleDebtMember2023-12-292024-09-260000062234srt:MaximumMemberus-gaap:ConvertibleDebtMember2023-12-292024-09-260000062234us-gaap:ConvertibleDebtMember2020-09-172020-09-170000062234us-gaap:ConvertibleDebtMember2024-09-2600000622342021-04-022024-06-2700000622342020-09-1700000622342020-09-172020-09-170000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-05-080000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-06-140000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-06-170000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-07-160000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-09-190000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2024-10-110000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-06-282024-09-260000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2023-12-292024-09-260000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-03-292024-09-260000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-06-142024-06-140000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMember2024-07-162024-07-160000062234mcs:ConvertibleSeniorNotesRepurchasesMemberus-gaap:ConvertibleDebtMemberus-gaap:SubsequentEventMember2024-10-112024-10-110000062234us-gaap:ConvertibleDebtMember2024-09-262024-09-260000062234srt:MinimumMember2024-09-260000062234srt:MaximumMember2024-09-260000062234mcs:LongTermOperatingLeaseObligationsMember2024-09-260000062234mcs:RestrictedStockAndRestrictedStockUnitsMembermcs:AfterTwoYearsMember2023-12-292024-09-260000062234mcs:RestrictedStockAndRestrictedStockUnitsMembermcs:AfterThreeYearsMember2023-12-292024-09-260000062234us-gaap:RestrictedStockMembermcs:AfterFourYearsMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMembermcs:EarningsBeforeInterestTaxesDepreciationAndAmortizationGrowthRateMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMembermcs:AverageReturnOnInvestedCapitalMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMembersrt:MinimumMember2023-12-292024-09-260000062234us-gaap:PerformanceSharesMembersrt:MaximumMember2023-12-292024-09-260000062234us-gaap:EmployeeStockOptionMember2023-12-280000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2023-12-280000062234us-gaap:PerformanceSharesMember2023-12-280000062234us-gaap:EmployeeStockOptionMember2023-12-292024-09-260000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2023-12-292024-09-260000062234us-gaap:EmployeeStockOptionMember2024-09-260000062234mcs:RestrictedStockAndRestrictedStockUnitsMember2024-09-260000062234us-gaap:PerformanceSharesMember2024-09-260000062234us-gaap:RestrictedStockUnitsRSUMember2023-12-292024-09-260000062234mcs:LoftonHotelMember2024-03-012024-03-310000062234mcs:LoftonHotelMember2024-03-310000062234mcs:TheMarcusCorporationMembermcs:LoftonHotelMember2024-04-012024-04-300000062234mcs:LoftonHotelMember2024-04-012024-04-300000062234mcs:LoftonHotelMember2024-09-260000062234mcs:HempelAndRobinsonParkMember2024-09-26
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 26, 2024
oTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number 1-12604
THE MARCUS CORPORATION
(Exact name of registrant as specified in its charter)
Wisconsin39-1139844
(State or other jurisdiction of
incorporation or organization)		(I.R.S. Employer
Identification No.)
111 East Kilbourn Avenue, Suite 1200
Milwaukee ,Wisconsin
53202-6628
(Address of principal executive offices)(Zip Code)
Registrant’s telephone number, including area code: (414) 905-1000
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading symbol(s)Name of each exchange on which registered
Common Stock, $1.00 par valueMCSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.
Yesx Noo
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
YesxNoo
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check One).
Large accelerated fileroAccelerated filerx
Non-accelerated fileroSmaller reporting companyo
Emerging growth companyo
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YesoNox
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
COMMON STOCK OUTSTANDING AT OCTOBER 29, 2024 – 24,497,446
CLASS B COMMON STOCK OUTSTANDING AT OCTOBER 29, 2024 –6,984,584

THE MARCUS CORPORATION
INDEX
2
PART I – FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements
THE MARCUS CORPORATION
Consolidated Balance Sheets
(in thousands, except share and per share data)
September 26,
2024		December 28,
2023
ASSETS
Current assets:
Cash and cash equivalents$28,415 $55,589 
Restricted cash4,630 4,249 
Accounts receivable, net of reserves of $176 and $115, respectively
28,309 19,703 
Other current assets26,391 22,175 
Total current assets87,745 101,716 
Property and equipment:
Land and improvements132,236 131,833 
Buildings and improvements733,972 719,521 
Leasehold improvements163,891 166,245 
Furniture, fixtures and equipment422,296 397,150 
Finance lease right-of-use assets29,219 30,106 
Construction in progress17,551 11,432 
Total property and equipment1,499,165 1,456,287 
Less accumulated depreciation and amortization812,172 774,025 
Net property and equipment686,993 682,262 
Operating lease right-of-use assets168,404 179,788 
Other assets:
Investments in joint ventures5,392 1,718 
Goodwill74,996 74,996 
Other23,429 24,623 
Total other assets103,817 101,337 
TOTAL ASSETS$1,046,959 $1,065,103 
See accompanying condensed notes to consolidated financial statements.
3
THE MARCUS CORPORATION
Consolidated Balance Sheets
(in thousands, except share and per share data)
September 26,
2024		December 28,
2023
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable$39,284 $37,384 
Income taxes847 — 
Taxes other than income taxes17,730 18,585 
Accrued compensation17,386 22,598 
Other accrued liabilities58,931 57,685 
Current portion of finance lease obligations2,546 2,579 
Current portion of operating lease obligations14,315 15,290 
Current maturities of long-term debt10,460 10,303 
Total current liabilities161,499 164,424 
Finance lease obligations10,989 12,753 
Operating lease obligations167,384 178,582 
Long-term debt162,633 159,548 
Deferred income taxes34,719 32,235 
Other long-term obligations47,443 46,389 
Shareholders’ Equity:
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued
— — 
Common Stock, $1 par; authorized 50,000,000 shares; issued 25,237,374 shares at September 26, 2024 and 24,691,548 shares at December 28, 2023
25,237 24,692 
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 6,984,584 shares at September 26, 2024 and 7,078,410 shares at December 28, 2023
6,985 7,078 
Capital in excess of par176,198 160,642 
Retained earnings266,211 281,599 
Accumulated other comprehensive loss(1,371)(1,336)
473,260 472,675 
Less cost of Common Stock in treasury (739,977 shares at September 26, 2024 and 47,916 shares at December 28, 2023)
(10,968)(1,503)
Total shareholders’ equity462,292 471,172 
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY$1,046,959 $1,065,103 
See accompanying condensed notes to consolidated financial statements.
4
THE MARCUS CORPORATION
Consolidated Statements of Earnings (Loss)
(in thousands, except per share data)
13 Weeks Ended39 Weeks Ended
September 26,
2024		September 28,
2023		September 26,
2024		September 28,
2023
Revenues:
Theatre admissions$68,980 $63,652 $158,156 $180,274 
Rooms40,019 36,456 88,728 82,959 
Theatre concessions62,118 54,551 141,230 156,633 
Food and beverage22,283 20,214 57,718 53,980 
Other revenues28,876 23,908 71,112 65,024 
222,276 198,781 516,944 538,870 
Cost reimbursements10,392 9,985 30,303 29,179 
Total revenues232,668 208,766 547,247 568,049 
Costs and expenses:
Theatre operations68,460 62,742 165,563 180,716 
Rooms12,300 11,594 32,875 31,232 
Theatre concessions24,062 20,738 57,463 59,069 
Food and beverage16,084 15,266 45,027 43,285 
Advertising and marketing6,645 6,025 18,448 16,703 
Administrative23,202 19,854 67,234 59,171 
Depreciation and amortization17,274 19,158 49,988 51,028 
Rent6,631 6,592 19,474 19,679 
Property taxes4,442 4,663 12,061 13,952 
Other operating expenses10,279 10,290 29,890 29,577 
Loss on disposition of property, equipment and other assets115 242 95 1,019 
Impairment charges— 684 472 684 
Reimbursed costs10,392 9,985 30,303 29,179 
Total costs and expenses199,886 187,833 528,893 535,294 
Operating income 32,782 20,933 18,354 32,755 
Other income (expense):
Investment income809 445 1,674 1,064 
Interest expense(3,062)(2,869)(8,160)(8,970)
Other income (expense)(390)(477)(1,121)(1,355)
Debt conversion expense(1,410)— (15,318)— 
Equity earnings (losses) from unconsolidated joint ventures(9)75 (446)(127)
(4,062)(2,826)(23,371)(9,388)
Earnings (loss) before income taxes28,720 18,107 (5,017)23,367 
Income tax expense5,406 5,873 3,756 7,133 
Net earnings (loss)$23,314 $12,234 $(8,773)$16,234 
Net earnings (loss) per share - basic:
Common Stock$0.74 $0.39 $(0.28)$0.52 
Class B Common Stock$0.69 $0.36 $(0.26)$0.48 
Net earnings (loss) per share - diluted:
Common Stock$0.73 $0.32 $(0.28)$0.46 
Class B Common Stock$0.69 $0.31 $(0.26)$0.46 
See accompanying condensed notes to consolidated financial statements.
5
THE MARCUS CORPORATION
Consolidated Statements of Comprehensive Income (Loss)
(in thousands)
13 Weeks Ended39 Weeks Ended
September 26,
2024		September 28,
2023		September 26,
2024		September 28,
2023
Net earnings (loss)$23,314 $12,234 $(8,773)$16,234 
Other comprehensive loss, net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax benefit of $4, $4, $13 and $13, respectively
(12)(12)(35)(35)
Fair market value adjustment of interest rate swap, net of tax benefit of $8
— — — (22)
Reclassification adjustment on interest rate swap included in interest expense, net of tax benefit of $20
— — — (58)
Other comprehensive loss(12)(12)(35)(115)
Comprehensive income (loss)$23,302 $12,222 $(8,808)$16,119 













See accompanying condensed notes to consolidated financial statements.
6
THE MARCUS CORPORATION
Consolidated Statements of Cash Flows
(in thousands)
39 Weeks Ended
September 26, 2024September 28, 2023
OPERATING ACTIVITIES:
Net earnings (loss)$(8,773)$16,234 
Adjustments to reconcile net loss to net cash used in operating activities:
Losses on investments in joint ventures446 127 
Distribution from joint venture— 200 
(Gain) loss on disposition of property, equipment and other assets95 1,019 
Impairment charges472 684 
Debt conversion expense15,318 — 
Depreciation and amortization49,988 51,028 
Amortization of debt issuance costs918 1,109 
Share-based compensation7,157 5,000 
Deferred income taxes2,496 6,586 
Other long-term obligations1,293 904 
Contribution of the Company’s stock to savings and profit-sharing plan— 1,259 
Changes in operating assets and liabilities:
Accounts receivable(3,851)59 
Other assets(175)(3,043)
Operating leases (541)(663)
Accounts payable(2,934)(4,389)
Income taxes1,060 (241)
Taxes other than income taxes(855)1,061 
Accrued compensation(5,212)(6,195)
Other accrued liabilities(5,528)(2,097)
Total adjustments60,147 52,408 
Net cash provided by operating activities51,374 68,642 
INVESTING ACTIVITIES:
Capital expenditures(53,770)(25,836)
Proceeds from disposals of property, equipment and other assets151 67 
Capital contribution in joint venture(5,620)— 
Subscription and sale of joint venture interests1,500 — 
Proceeds from sale of trading securities37 17 
Purchase of trading securities(1,148)(839)
Other investing activities453 (291)
Net cash used in investing activities(58,397)(26,882)
FINANCING ACTIVITIES:
Debt transactions:
Proceeds from borrowings on revolving credit facility81,000 38,000 
Repayment of borrowings on revolving credit facility(81,000)(38,000)
Proceeds from issuance of long-term debt100,000 — 
Principal payments on long-term debt(11,024)(11,097)
Repayment of borrowing on insurance policy— (6,700)
Repurchase of convertible senior notes(102,525)— 
Proceeds from capped call unwind13,230 — 
Debt issuance costs(1,083)(82)
Principal payments on finance lease obligations(1,842)(1,904)
Equity transactions:
Treasury stock transactions, except for stock options(9,911)(526)
Exercise of stock options— 222 
Dividends paid(6,615)(5,273)
Distributions to noncontrolling interest— (824)
Net cash used in financing activities(19,770)(26,184)
Net increase (decrease) in cash, cash equivalents and restricted cash(26,793)15,576 
Cash, cash equivalents and restricted cash at beginning of period59,838 24,506 
Cash, cash equivalents and restricted cash at end of period$33,045 $40,082 
Supplemental Information:
Interest paid, net of amounts capitalized$8,630 $9,542 
Income taxes paid, including interest earned(201)(788)
Change in accounts payable for additions to property, equipment and other assets4,834 1,550 
See accompanying condensed notes to consolidated financial statements.
7
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)


1. General
Basis of Presentation - The unaudited consolidated financial statements for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at September 26, 2024, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 28, 2023.
Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 28, 2023, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.
Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $17,277 and $49,992 for the 13 and 39 weeks ended September 26, 2024, respectively, and $19,150 and $51,004 for the 13 and 39 weeks ended September 28, 2023, respectively.
Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset.
Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value.
During the 39 weeks ended September 26, 2024, the Company determined that indicators of impairment were present at one asset group for a leased theatre location that the Company made the decision to close during the second quarter of fiscal 2024. As such, the Company evaluated the fair value of these assets, consisting primarily of land improvements, leasehold improvements, building, furniture, fixtures and equipment, and operating lease right-of-use assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset), was less than their carrying values and recorded a $472 impairment loss, reducing certain property and equipment and certain operating lease net obligations. The remaining net book value of the impaired assets as of the date of the asset write-down (June 27, 2024) was $0.
During the 13 weeks ended September 28, 2023, the Company determined that indicators of impairment were present at one theatre asset group. As such, the Company evaluated the fair value of these assets, consisting primarily of land, building and furniture, fixtures and equipment, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $684 impairment loss, reducing certain property and equipment assets. The remaining net book value of the impaired assets as of the date of the asset write-down (September 28, 2023) was $3,040.
Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 39 weeks ended September 26, 2024 or September 28, 2023.
Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options, restricted stock units, performance stock units and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.
Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.
The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Net earnings (loss) per share - basic:
Common Stock$0.74 $0.39 $(0.28)$0.52 
Class B Common Stock$0.69 $0.36 $(0.26)$0.48 
Net earnings (loss) per share - diluted:
Common Stock$0.73 $0.32 $(0.28)$0.46 
Class B Common Stock$0.69 $0.31 $(0.26)$0.46 
Numerator:
Net earnings (loss) $23,314 $12,234 $(8,773)$16,234 
Denominator (in thousands):
Denominator for basic EPS31,953 31,691 32,002 31,645 
Effect of dilutive employee stock options17 41 — 48 
Effect of restricted stock units47 — — — 
Effect of convertible senior notes14 9,242 — 9,242 
Diluted weighted-average shares outstanding32,031 40,974 32,002 40,935 
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):
Employee stock options2,800 2,965 2,809 2,965 
Restricted stock units— — 49 — 
Performance stock units139 — 141 — 
Convertible senior notes— — 14 — 
Total2,939 2,965 3,013 2,965 
For the periods when the Company reports a net loss, common stock equivalents, restricted stock units, performance stock units, and shares related to the convertible senior notes are excluded from the computation of diluted loss per share as their inclusion would have an anti-dilutive effect. Performance stock units are considered anti-dilutive if the performance targets upon which the issuance of the shares are contingent have not been achieved and the respective performance period has not been completed as of the end of the current period. Shares related to the convertible senior notes are excluded from the computation of diluted earnings per share in periods when the effect would have been anti-dilutive using the if-converted method.
Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 39 weeks ended September 26, 2024 and September 28, 2023 was as follows:
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Total Shareholders’
Equity
BALANCES AT DECEMBER 28, 2023$24,692 $7,078 $160,642 $281,599 $(1,336)$(1,503)$471,172 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (449)— — (449)
$0.07 per share Common Stock
— — — (1,760)— — (1,760)
Purchase of treasury stock— — — — — (301)(301)
Reissuance of treasury stock— — (3)— — 23 20 
Issuance of non-vested stock452 — (515)— — 63 — 
Shared-based compensation— — 2,514 — — — 2,514 
Conversions of Class B Common Stock93 (93)— — — — — 
Comprehensive loss— — — (11,866)(12)— (11,878)
BALANCES AT MARCH 28, 202425,237 6,985 162,638 267,524 (1,348)(1,718)459,318 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.07 per share Common Stock
— — — (1,763)— — (1,763)
Reissuance of treasury stock— — (7)— — 23 16 
Issuance of non-vested stock— — (326)— — 326 — 
Shared-based compensation— — 2,418 — — — 2,418 
Convertible senior note repurchase— — (2,788)— — — (2,788)
Capped call unwind— — 12,904 — — — 12,904 
Comprehensive loss— — — (20,221)(11)— (20,232)
BALANCES AT JUNE 27, 202425,237 6,985 174,839 245,093 (1,359)(1,369)449,426 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.070 per share Common Stock
— — — (1,749)— — (1,749)
Purchase of treasury stock— — — — — (9,667)(9,667)
Reissuance of treasury stock— — 6 — — 16 22 
Issuance of non-vested stock— — (52)— — 52 — 
Shared-based compensation— — 2,225 — — — 2,225 
Convertible senior note repurchase— — (5,472)— — — (5,472)
Capped call unwind— — 4,652 — — — 4,652 
Comprehensive income — — — 23,314 (12)— 23,302 
BALANCES AT SEPTEMBER 26, 2024$25,237 $6,985 $176,198 $266,211 $(1,371)$(10,968)$462,292 
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Shareholders’
Equity
Attributable
to The
Marcus
Corporation		Non-
controlling
Interest		Total
Equity
BALANCES AT DECEMBER 29, 2022$24,498 $7,111 $153,794 $274,254 $(1,694)$(1,866)$456,097 $824 $456,921 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,229)— — (1,229)— (1,229)
Exercise of stock options— — (1)— — 3 2 — 2 
Purchase of treasury stock— — — — — (313)(313)— (313)
Savings and profit-sharing contribution79 — 1,180 — — — 1,259 — 1,259 
Reissuance of treasury stock— — (3)— — 24 21 — 21 
Issuance of non-vested stock82 — (143)— — 61 — — — 
Shared-based compensation— — 2,172 — — — 2,172 — 2,172 
Other— — 1 (1)— — — — — 
Conversions of Class B Common Stock33 (33)— — — — — — — 
Distribution to noncontrolling interest— — — — — — — (550)(550)
Comprehensive loss— — — (9,466)(91)— (9,557)— (9,557)
BALANCES AT MARCH 30, 202324,692 7,078 157,000 263,239 (1,785)(2,091)448,133 274 448,407 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,230)— — (1,230)— (1,230)
Exercise of stock options— — (25)— — 121 96 — 96 
Purchase of treasury stock— — — — — (226)(226)— (226)
Reissuance of treasury stock— — (204)— — 223 19 — 19 
Issuance of non-vested stock— — (55)— — 55 — — — 
Shared-based compensation— — 1,515 — — — 1,515 — 1,515 
Other— — — 1 — (1)— — — 
Distribution to noncontrolling interest— — — — — — — (274)(274)
Comprehensive income (loss)— — — 13,466 (12)— 13,454 — 13,454 
BALANCES AT JUNE 29, 202324,692 7,078 158,231 275,157 (1,797)(1,919)461,442 — 461,442 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (453)— — (453)— (453)
$0.07 per share Common Stock
— — — (1,723)— — (1,723)— (1,723)
Exercise of stock options— — (184)— — 1,171 987 — 987 
Purchase of treasury stock— — — — — (914)(914)— (914)
Reissuance of treasury stock— — (3)— — 27 24 — 24 
Issuance of non-vested stock— — (53)— — 53 — — — 
Shared-based compensation— — 1,313 — — — 1,313 — 1,313 
Comprehensive income — — — 12,234 (12)— 12,222 — 12,222 
BALANCES AT SEPTEMBER 28, 2023$24,692 $7,078 $159,304 $285,215 $(1,809)$(1,582)$472,898 $— $472,898 

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
September 26,
2024		December 28,
2023
Net unrecognized actuarial loss for pension obligation$(1,371)$(1,336)
$(1,371)$(1,336)
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.
The Company’s assets and liabilities measured at fair value are classified in one of the following categories:
Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At September 26, 2024 and December 28, 2023, the Company’s $7,332 and $5,364 respectively, of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At September 26, 2024 and December 28, 2023, the Company’s $15,014 and $37,018, respectively, of investments in money market funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents.
Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities were measured using Level 2 pricing inputs.
Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets that are measured on a non-recurring basis are discussed above under Long-Lived Assets.
The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $160,000 of senior notes, valued using Level 2 pricing inputs, is approximately $160,917 at September 26, 2024, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $13,649 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $20,183 at September 26, 2024, determined based on market rates and the closing trading price of the convertible senior notes as of September 26, 2024. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.
Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Service cost$62 $122 $186 $366 
Interest cost445 453 1,334 1,358 
Net amortization of prior service cost and actuarial loss(16)(16)(48)(48)
Net periodic pension cost$491 $559 $1,472 $1,676 
Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.
Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 26, 2024 is as follows:
13 Weeks Ended September 26, 2024
TheatresHotels/Resorts CorporateTotal
Theatre admissions$68,980 $— $— $68,980 
Rooms— 40,019 — 40,019 
Theatre concessions62,118 — — 62,118 
Food and beverage— 22,283 — 22,283 
Other revenues(1)
12,090 16,699 87 28,876 
  Revenue before cost reimbursements143,188 79,001 87 222,276 
Cost reimbursements655 9,737 — 10,392 
Total revenues$143,843 $88,738 $87 $232,668 
39 Weeks Ended September 26, 2024
TheatresHotels/ResortsCorporateTotal
Theatre admissions$158,156 $— $— $158,156 
Rooms— 88,728 — 88,728 
Theatre concessions141,230 — — 141,230 
Food and beverage— 57,718 — 57,718 
Other revenues(1)
26,524 44,338 250 71,112 
  Revenue before cost reimbursements325,910 190,784 250 516,944 
Cost reimbursements655 29,648 — 30,303 
Total revenues$326,565 $220,432 $250 $547,247 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 28, 2023 is as follows:
13 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$63,652 $— $— $63,652 
Rooms— 36,456 — 36,456 
Theatre concessions54,551 — — 54,551 
Food and beverage— 20,214 — 20,214 
Other revenues(1)
8,382 15,443 83 23,908 
  Revenue before cost reimbursements126,585 72,113 83 198,781 
Cost reimbursements— 9,985 — 9,985 
Total revenues$126,585 $82,098 $83 $208,766 
39 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$180,274 $— $— $180,274 
Rooms— 82,959 — 82,959 
Theatre concessions156,633 — — 156,633 
Food and beverage— 53,980 — 53,980 
Other revenues(1)
22,904 41,857 263 65,024 
  Revenue before cost reimbursements359,811 178,796 263 538,870 
Cost reimbursements— 29,179 — 29,179 
Total revenues$359,811 $207,975 $263 $568,049 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The Company had deferred revenue from contracts with customers of $34,463 and $38,034 as of September 26, 2024 and December 28, 2023, respectively. The Company had no contract assets as of September 26, 2024 and December 28, 2023. During the 39 weeks ended September 26, 2024, the Company recognized revenue of $17,208 that was included in deferred revenues as of December 28, 2023. During the 39 weeks ended September 28, 2023, the Company recognized revenue of $14,545 that was included in deferred revenues as of December 29, 2022. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $2,031 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $14,181 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,074 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.
The majority of the Company’s revenue is recognized in less than one year from the original contract.
New Accounting Pronouncements - In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280: Improvements to Reportable Segment Disclosures (ASU No. 2023-07), which requires disclosure of incremental segment information on an annual and interim basis. ASU No 2023-07 will be effective for the Company’s fiscal year ending December 26, 2024, and the Company’s interim periods beginning in fiscal 2025. The Company is evaluating the effect that the guidance will have on its consolidated financial statement disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740: Improvements to Income Tax Disclosures (ASU No. 2023-09), which requires improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid information. ASU No. 2023-09 will be effective for the Company in fiscal 2025 and must be applied prospectively with retrospective application permitted. The Company is evaluating the impact that ASU No. 2023-09 will have on its consolidated financial statement disclosures.
2. Long-Term Debt
Long-term debt is summarized as follows:
September 26, 2024December 28, 2023
Senior notes$160,000 $70,000 
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%
192 528 
Convertible senior notes13,649 100,050 
Payroll Protection Program loans544 1,233 
Revolving credit agreement— — 
Debt issuance costs(1,292)(1,960)
Total debt, net of debt issuance costs173,093 169,851 
Less current maturities, net of issuance costs10,460 10,303 
Long-term debt$162,633 $159,548 
Credit Agreement
As of September 26, 2024, the Company has a Credit Agreement that provides for a revolving credit facility that matures on October 16, 2028 with an initial maximum aggregate amount of availability of $225,000. At September 26, 2024, there were no borrowings outstanding on the revolving credit facility, which when borrowed, bear interest at the secured overnight financing rate (SOFR) plus a margin (as discussed further below), effectively 6.60% at September 26, 2024. Availability under the $225,000 revolving credit facility was $220,185 as of September 26, 2024 after taking into consideration outstanding letters of credit that reduce revolver availability.
Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) the term SOFR, plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date, or (ii) the alternate base rate (“ABR”) (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date. The revolving credit facility also requires an annual facility fee equal to 0.175% to 0.275% of the total revolving commitments depending on the Company’s consolidated net leverage ratio.
The Credit Agreement includes, among other restrictions and covenants applicable to the Company, a requirement that the Company’s consolidated net leverage ratio not exceed 3.50:1.00, provided that, with some limitations, such ratio may be increased to 4.00:1:00 for the full fiscal quarter in which a material acquisition (in which aggregate consideration equals or
8
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

exceeds $30,000) is consummated and the three fiscal quarters immediately thereafter, and a requirement that the Company’s interest coverage ratio at the end of any fiscal quarter not be less than 3.00:1.00.
In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement.
The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.
Note Purchase Agreements
At September 26, 2024, the Company’s $160,000 of senior notes consisted of three Note Purchase Agreements maturing in 2025 through 2034, which require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 7.02%. The weighted average fixed rate of the $160,000 senior notes was 5.94% as of September 26, 2024.
During the 13 weeks ended September 26, 2024, on July 9, 2024, the Company entered into a Master Note Purchase Agreement with several purchasers party to the agreement, pursuant to which the Company issued and sold $100,000 aggregate principal amount of senior notes in two tranches: (i) $60,000 in aggregate principal amount of the Company’s 6.89% Series 2024 Senior Notes, Tranche A due July 9, 2031 (the “Tranche A Notes”) and (ii) $40,000 in aggregate principal amount of the Company’s 7.02% Series 2024 Senior Notes, Tranche B due July 9, 2034 (the “Tranche B Notes” and, collectively with the Tranche A Notes, the “2024 Senior Notes”). The net proceeds were used to refinance the Convertible Notes Repurchases of $99,901 aggregate principal amount of Convertible Notes (see below) and for general corporate purposes.
Interest on the 2024 Senior Notes is payable semi-annually in arrears on the 9th day of January and July each year, commencing on January 9, 2025, and on the applicable maturity date. The Tranche A Notes require annual principal amortization payments beginning in fiscal 2027 with a final maturity in fiscal 2031. The Tranche B Notes require annual principal amortization payments beginning in fiscal 2028 with a final maturity in fiscal 2034. The Master Note Purchase Agreement contains various restrictions and covenants applicable to the Company and certain of its subsidiaries that are consistent with the restrictions, covenants and collateral provisions in the Company’s existing Credit Agreement and Note Purchase Agreements.
Convertible Senior Notes
On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.
The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day
9
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.
Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate was 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. The conversion rate is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At September 26, 2024, the applicable conversion rate is 94.3588 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an applicable conversion price of approximately $10.60 per share of Common Stock). The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes.
Since the Company’s fiscal 2021 second quarter through the Company’s fiscal 2024 second quarter, the Company’s Convertible Notes were eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. During the Company’s fiscal 2024 third quarter the Convertible Notes were not eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was not greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. The Convertible Notes are eligible for conversion at the option of the holders during the Company’s fiscal 2024 fourth quarter.
In connection with the pricing of the Convertible Notes on September 17, 2020, and in connection with the exercise by the Initial Purchasers (as defined in the Convertible Notes purchase agreement) of their option to purchase additional Convertible Notes on September 18, 2020, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain of the Initial Purchasers and/or their respective affiliates and/or other financial institutions (the “Capped Call Counterparties”). The Capped Call Transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of the Convertible Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of such converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the Capped Call Transactions. The cap price of the Capped Call Transactions was initially $17.98 per share (in no event shall the cap price be less than the strike price of $11.0128), which represents a premium of 100% over the last reported sale price of the Common Stock of $8.99 per share on The New York Stock Exchange on September 17, 2020. Under the terms of the Capped Call Transactions, the cap price is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At September 26, 2024, the adjusted cap price is approximately $17.30 per share. The Capped Call Transactions are separate transactions entered into by the Company with the Capped Call Counterparties, are not part of the terms of the Convertible Notes and will not change the rights of holders of the Convertible Notes under the Convertible Notes and the Indenture.
Convertible Senior Notes Repurchases
During the 39 weeks ended September 26, 2024, the Company entered into separate, privately negotiated purchase agreements (the “Purchase Agreements”) with certain holders of its Convertible Notes. Under the terms of the Purchase
10
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

Agreements, the holders agreed to exchange $99,901 in aggregate principal amount of Convertible Notes for cash consideration of $121,511 (or $103,314 net of the cash received by the Company in connection with the unwind of a portion of the Capped Call Transactions as discussed below) effected over three separate repurchase tranches (the “Convertible Notes Repurchases”). On May 8, 2024, the Company entered into the first repurchase transaction to retire $40,000 of aggregate principal amount of Convertible Notes for $45,879 in cash consideration plus accrued interest, with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, the Company entered into the second repurchase transaction to retire $46,401 of aggregate principal amount of Convertible Notes for $55,208 in cash consideration plus accrued interest, with settlement occurring during the fiscal third quarter on July 16, 2024. On September 19, 2024, the Company entered into the third repurchase transaction to retire $13,500 of aggregate principal amount of Convertible Notes for $20,424 in cash consideration plus accrued interest, with settlement occurring during the fiscal fourth quarter on October 11, 2024. Following settlement of the Convertible Note Repurchases on October 11, 2024, the aggregate principal amount of Convertible Notes outstanding was $149. During the 13 and 39 weeks ended September 26, 2024, the Company incurred debt conversion expense of $1,410 and $15,318, respectively, in connection with the Convertible Notes Repurchases.
In connection with the Convertible Notes Repurchases, the Company entered into unwind agreements with the Capped Call Counterparties to terminate a portion of the Capped Call Transactions equal to the notional amounts of the Convertible Notes Repurchases, and for the Company to receive aggregate cash of $18,197 effected over three separate unwind tranches. On May 8, 2024, the Company entered into the first tranche of unwind agreements and received $5,770 in cash consideration with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, the Company entered into the second tranche of unwind agreements and received $7,460 in cash consideration at settlement occurring during the fiscal third quarter on July 16, 2024. On September 19, 2024, the Company entered into the third tranche of unwind agreements and received $4,967 in cash consideration at settlement occurring during the fiscal fourth quarter on October 11, 2024.
3. Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to Accounting Standards Codification No. 842, Leases. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
11
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

Total lease cost consists of the following:
13 Weeks Ended39 Weeks Ended
Lease CostClassificationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Finance lease costs: 
Amortization of finance lease assetsDepreciation and amortization$555 $695 $1,724 $2,074 
Interest on lease liabilitiesInterest expense173 187 508 577 
$728 $882 $2,232 $2,651 
Operating lease costs:
Operating lease costsRent expense$5,891 $6,027 $18,009 $18,104 
Variable lease costRent expense646 526 1,248 1,469 
Short-term lease costRent expense94 39 217 106 
$6,631 $6,592 $19,474 $19,679 
Additional information related to leases is as follows:
13 Weeks Ended39 Weeks Ended
Other InformationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases$628 $703 $1,842 $1,904 
Operating cash flows from finance leases173 187 508 577 
Operating cash flows from operating leases6,067 6,308 18,876 19,167 
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities73 181 188 317 
Operating lease liabilities983 261 3,095 261 
September 26, 2024December 28, 2023
Finance leases:
Property and equipment – gross$29,219 $30,106 
Accumulated depreciation and amortization(18,730)(17,956)
Property and equipment - net$10,489 $12,150 
12
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

Remaining lease terms and discount rates are as follows:
Lease Term and Discount RateSeptember 26, 2024December 28, 2023
Weighted-average remaining lease terms:
Finance leases6 years7 years
Operating leases11 years12 years
Weighted-average discount rates:
Finance leases4.68 %4.62 %
Operating leases4.70 %4.52 %
Deferred rent payments of approximately $590 for the Company’s operating leases have been included in the total operating lease obligations as of September 26, 2024, of which approximately $141 is included in long-term operating lease obligations.
4. Share Based Compensation
During the 39 weeks ended September 26, 2024, the Company granted restricted stock, restricted stock units (RSUs) and performance stock units (PSUs) to certain executives and associates.

Restricted Stock and Restricted Stock Units
During the 39 weeks ended September 26, 2024, the Company granted (i) an annual award of restricted stock and RSUs with a vesting period of 50% after two years and 100% after three years, and (ii) a special long-term incentive and retention award of restricted stock to certain executives with a vesting period of 100% after four years, or upon retirement after three years. Restricted stock awards are issued and outstanding common stock at the time of the grant and become unrestricted upon the vesting date. RSU awards are payable in common stock upon vesting. The Company expenses the cost of restricted stock and RSU awards over the vesting period based on the fair value of the award at the date of grant.

Performance Stock Units
During the 39 weeks ended September 26, 2024, the Company granted PSUs with vesting subject to the Company’s achievement of performance goals expressed in terms of (i) earnings before interest, taxes, depreciation and amortization, or EBITDA, growth rate ranking relative to the Russell 2000 Index with respect to 25% of the total number of performance stock unit awards, and (ii) the Company’s average return on invested capital, or ROIC, ranking relative to the Russell 2000 Index with respect to 75% of the total number of performance stock unit awards. For grants awarded in fiscal 2024, the PSU performance goals relate to the three-year performance period from fiscal 2024-2026. PSUs are payable at the end of their respective performance period in common stock, and the number of PSUs awarded can range from zero to 150% depending on the Company’s achievement of the relative performance metrics. The Company expenses the cost of PSUs based on the fair value of the awards at the date of grant and the estimated achievement of the performance metric, ratable over the performance period of three fiscal years.
13
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

A summary of the Company’s stock option, restricted stock and RSU and PSU activity and related information follows, with PSUs reflected at the target achievement percentage until the completion of the performance period (shares in thousands):
Stock OptionsRestricted Stock & RSUsPSUs
OptionsWeighted-Average Exercise PriceShares / UnitsWeighted-Average Fair ValueUnitsWeighted-Average Fair Value
December 28, 20233,173 $22.69 238 $17.41 — $— 
Granted— — 503 14.83 143 14.84 
Exercised (1)
— — — — — — 
Vested (2)
— — (47)21.35 — — 
Forfeited(156)18.92 (4)14.84 (4)14.84 
September 26, 20243,017 $22.88 690 $15.28 139 $14.84 
(1)Exercise activity only applicable to stock options.
(2)Vesting activity not applicable to stock options.
Share-based compensation expense was $2,225 and $7,157, respectively, during the 13 and 39 weeks ended September 26, 2024, and $1,313 and $5,000, respectively, during the 13 and 39 weeks ended September 28, 2023. As of September 26, 2024, total unrecognized share-based compensation expense related to stock options was $1,909, which will be amortized to expense over the weighted-average remaining life of 1.9 years. As of September 26, 2024, total unrecognized share-based compensation expense related to non-vested restricted stock, RSUs and PSUs was $6,645, which will be amortized over the weighted-average remaining service period of 2.9 years.
At September 26, 2024, there were 117,441 shares available for grants of additional stock options, restricted stock, RSUs, PSUs and other types of equity awards under the current plan.
5. Income Taxes
The Company’s effective income tax rate for the 13 and 39 weeks ended September 26, 2024 was 18.9% and (74.9)%, respectively, and 32.4% and 30.5% for the 13 and 39 weeks ended September 28, 2023, respectively. The fiscal 2024 first three quarters effective income tax rate was negatively impacted by a nondeductible debt conversion expense resulting from the Convertible Notes Repurchases and a $1,217 reduction in deferred tax assets resulting from the related termination of the Capped Call Transactions and excess compensation subject to deduction limitations.
6. Joint Venture Transactions
In March 2024, the Company formed a joint venture with Hempel Real Estate (“Hempel”) and Robinson Park (“RP”) to acquire the Loews Minneapolis Hotel, a 251 guest room and suite full-service lifestyle hotel located in downtown Minneapolis, Minnesota. The acquired hotel was rebranded as The Lofton Hotel (“Lofton”) under the Tapestry Collection by Hilton flag. The Company invested $5,620 for a 33.3% equity interest in the Lofton joint venture and entered into a management agreement for the hotel. Subsequent to its initial investment in the joint venture, the Company sold an 8.6% interest to a minority investor for $1,500, reducing its equity interest in the Lofton joint venture to 24.7%. The Company accounts for its investment in the Lofton joint venture on the equity method.
A wholly-owned subsidiary of the Lofton joint venture entity, as the borrower, financed the acquisition of and future improvements to the hotel with a mortgage loan. In connection with this mortgage loan, the Company provided an environmental indemnity and a several payment guaranty that provides that the lender can recover losses from the Company, a principal in Hempel, and a principal in RP for certain events of default of the borrower up to $6,200 for the Company. Under the terms of a cross-indemnity agreement among the guarantors, the other two guarantors have fully indemnified the Company under the guarantees for any losses in excess of its proportionate liability under the several payment guaranty and environmental indemnity.
14
THE MARCUS CORPORATION
CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
FOR THE 13 AND 39 WEEKS ENDED SEPTEMBER 26, 2024
(in thousands, except share and per share data)

7. Business Segment Information
The Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.
Following is a summary of business segment information for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023:
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$143,843 $88,738 $87 $232,668 
Operating income (loss)21,761 17,041 (6,020)32,782 
Depreciation and amortization11,347 5,789 138 17,274 
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$126,585 $82,098 $83 $208,766 
Operating income (loss)11,377 14,377 (4,821)20,933 
Depreciation and amortization14,258 4,817 83 19,158 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$326,565 $220,432 $250 $547,247 
Operating income (loss)18,803 17,996 (18,445)18,354 
Depreciation and amortization33,900 15,701 387 49,988 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$359,811 $207,975 $263 $568,049 
Operating income (loss)32,707 15,450 (15,402)32,755 
Depreciation and amortization37,063 13,706 259 51,028 
15
THE MARCUS CORPORATION
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Quarterly Report on Form 10-Q and the accompanying Management’s Discussion and Analysis, are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects future pandemics or epidemics may have on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (including disruptions in the production of films due to events such as a strike by actors, writers or directors or future pandemics); (3) the effects of theatre industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets; (5) the effects of adverse economic conditions on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States or other incidents of violence in public venues such as hotels and movie theatres; and (14) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.
RESULTS OF OPERATIONS
General
We report our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December. Fiscal 2024 is a 52-week year beginning on December 29, 2023 and ending on December 26, 2024. Fiscal 2023 was a 52-week year that began on December 30, 2022 and ended on December 28, 2023.
We divide our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. The third quarter of fiscal 2024 consisted of the 13-week period beginning on June 28, 2024 and ended on September 26, 2024. The third quarter of fiscal 2023 consisted of the 13-week period beginning June 30, 2023 and ended on September 28, 2023. Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.
16
Overall Results
The following table sets forth revenues, operating income, other income (expense), net earnings (loss) and net earnings (loss) per diluted common share for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for per share and variance percentage data):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct.F2024F2023Amt.Pct.
Revenues$232.7 $208.8 $23.9 11.4 %$547.2 $568.0 $(20.8)(3.7)%
Operating income32.8 20.9 11.8 56.6 %18.4 32.8 (14.4)(44.0)%
Other income (expense)(4.1)(2.8)(1.2)(43.7)%(23.4)(9.4)(14.0)(148.9)%
Net earnings (loss)$23.3 $12.2 $11.1 90.6 %$(8.8)$16.2 $(25.0)(154.0)%
Net earnings (loss) per common share - diluted$0.73 $0.32 $0.41 128.1 %$(0.28)$0.46 $(0.74)(160.9)%
Revenues increased during the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023 due to increased revenues from both our theatre division and hotels and resorts division. Revenues decreased during the first three quarters of fiscal 2024 compared to the first three quarters of fiscal 2023 due to a decrease in revenues from our theatre division, partially offset by increased revenues from our hotels and resorts division.
Operating income increased during the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023 due to increased operating income from both our theatre division and hotels and resorts division, partially offset by an increase in corporate operating losses. Operating income decreased during the first three quarters of fiscal 2024 compared to the first three quarters of fiscal 2023 primarily due to a decrease in operating income from our theatre division and an increase in corporate operating losses, partially offset by increased operating income from our hotels and resorts division.
Net earnings and net earnings per diluted common share increased during the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023 due to increased operating income and investment income, partially offset by the impact of debt conversion expense. Net earnings (loss) and net earnings (loss) per diluted common share decreased during the first three quarters of fiscal 2024 compared to the first three quarters of fiscal 2023 due to decreased operating income and the impact of debt conversion expense, partially offset by increased investment income and lower interest expense.
Other income (expense) during the third quarter and first three quarters of fiscal 2024 were negatively impacted by debt conversion expense of $1.4 million and $15.3 million, respectively, in connection with the $99.9 million aggregate principal amount of Convertible Notes Repurchases. See Convertible Senior Notes Repurchases in the “Liquidity and Capital Resources” section of this MD&A for further discussion.
We recognized investment income of $0.8 million and $1.7 million during the third quarter and first three quarters of fiscal 2024, respectively, compared to $0.4 million and $1.1 million during the third quarter and first three quarters of fiscal 2023, respectively. Variations in investment income were due to changes in the value of marketable securities.
Our interest expense totaled $3.1 million and $8.2 million for the third quarter and first three quarters of fiscal 2024, respectively, compared to $2.9 million and $9.0 million for the third quarter and first three quarters of fiscal 2023, respectively. The decrease in interest expense during the first three quarters of fiscal 2024 was primarily due to decreased borrowings and a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.
We reported income tax expense for the third quarter of fiscal 2024 of $5.4 million compared to income tax expense of $5.9 million during the third quarter of fiscal 2023. We reported income tax expense for the first three quarters of fiscal 2024 of $3.8 million compared to income tax expense of $7.1 million during the first three quarters of fiscal 2023. Our fiscal 2024 first three quarters effective income tax rate was (74.9)%, and was negatively impacted by nondeductible debt conversion expense resulting from the Convertible Notes Repurchases and a $1.2 million reduction in deferred tax assets resulting from the related termination of the Capped Call Transactions (combined negative impact of approximately 108
17
percentage points) and excess compensation subject to deduction limitations. Our fiscal 2023 first three quarters effective income tax rate was 30.5%. We anticipate that our effective income tax rate for fiscal 2024 may be in the (200)% to (210)% range, which includes an estimated negative impact of approximately 240 percentage points from the Convertible Notes Repurchases and termination of the Capped Call Transactions, and excludes any potential changes in federal or state income tax rates, valuation allowance adjustments or other one-time tax benefits. Our actual fiscal 2024 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.
Theatres
The following table sets forth revenues, operating income and operating margin for our theatre division for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for variance percentage and operating margin):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct.F2024F2023Amt.Pct.
Revenues$143.8 $126.6 $17.3 13.6 %$326.6 $359.8 $(33.2)(9.2)%
Operating income21.8 11.4 10.4 91.3 %18.8 32.7 (13.9)(42.5)%
Operating margin (% of revenues)15.1 %9.0 % 5.8 %9.1 % 
Our theatre division revenues and operating income increased with stronger performances from blockbuster films during the third quarter of fiscal 2024, compared to the third quarter of fiscal 2023. During the first three quarters of fiscal 2024, our theatre division revenues and operating income decreased compared to the first three quarters of fiscal 2023, driven by a weaker film slate in the first half of fiscal 2024, partially offset by an increase in film performance in the third quarter. The film slate in the first three quarters of fiscal 2024 was negatively impacted by the content supply chain disruption from the shutdown of movie production during the WGA and SAG-AFTRA labor strikes in 2023, which contributed to a weaker slate of available films, particularly in the first half of fiscal 2024, compared to the first three quarters of fiscal 2023, resulting in decreased theatre attendance.
The following table provides a further breakdown of the components of revenues for the theatre division for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for variance percentage):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct.F2024F2023Amt.Pct.
Admission revenues$69.0 $63.7 $5.3 8.4 %$158.2 $180.3 $(22.1)(12.3)%
Concession revenues62.1 54.6 7.6 13.9 %141.2 156.6 (15.4)(9.8)%
Other revenues12.1 8.4 3.7 44.2 %26.5 22.9 3.6 15.8 %
Total revenues143.2 126.6 16.6 13.1 %325.9 359.8 (33.9)(9.4)%
According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal 2024 third quarter and first three quarters results, U.S. box office receipts increased 3.8% during our fiscal 2024 third quarter compared to the same comparable weeks in fiscal 2023, indicating that our increase of 9.5% in admission revenues for comparable theatres (excluding theatres closed during the past year) during the third quarter of fiscal 2024 outperformed the industry by 5.7 percentage points. We believe our over-performance is attributable to a favorable film mix during the third quarter of fiscal 2024 that included Deadpool & Wolverine, Despicable Me 4, Twisters, Inside Out 2, and It Ends with Us, that was more appealing to audiences in our Midwestern markets. Additionally, we believe changes to our Value Tuesday program made during the second quarter of fiscal 2024, including reintroducing free complimentary-sized popcorn for Magical Movie Reward (MMR) members on Tuesdays, have positively contributed to our outperformance.
Data received and complied by us from Comscore also indicates U.S. box office receipts decreased 11.0% during the first three quarters of fiscal 2024 compared to the same comparable weeks in fiscal 2023, indicating that our decrease of 11.3% in admission revenues for comparable theatres (excluding theatres closed during the past year) during the first three quarters of fiscal 2024 underperformed the industry by 0.3 percentage points. We believe the slight underperformance during the first three quarters of fiscal 2024 is due to an unfavorable film mix primarily during the first half of fiscal 2024
18
that was more appealing to audiences in other parts of the U.S. than in our Midwestern markets compared to a favorable film mix during the first half of fiscal 2023, partially offset by a favorable film slate and increased performance in the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023.
Additional data received and compiled by us from Comscore indicates our admission revenues at comparable theatres during the third quarter and first three quarters of fiscal 2024 represented approximately 3.1% and 3.0%, respectively, of the total admission revenues in the U.S. (commonly referred to as market share in our industry), compared to 2.9% and 3.1% during the third quarter and first three quarters of fiscal 2023, respectively. Our goal is to continue our historical long-term pattern of outperforming the industry, but our ability to do so in any given quarter will likely be partially dependent upon film mix, weather and the competitive landscape in our markets.
Total theatre attendance for our comparable theatres increased 7.1% during the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023, which was primarily attributable to a stronger film slate, higher box office performance from the top films during the third quarter of fiscal 2024 versus the top films last fiscal year during the third quarter, and an increase in the number of films released during the fiscal 2024 third quarter. During the third quarter of fiscal 2024 there were 30 wide-release films (films showed in over approximately 1,500 theatres in the U.S.) compared to 24 wide-release films during the third quarter of fiscal 2023.
Total theatre attendance for our comparable theatres decreased 11.8% during the first three quarters of fiscal 2024 compared to the prior year period, resulting primarily from the weaker film slate in the first half of fiscal 2024, partially offset by an increase in theatre attendance during fiscal 2024 third quarter compared to the prior year quarter. During the first three quarters of fiscal 2024 there were 82 wide-release films compared to 76 wide-release films during the first three quarters of fiscal 2023, with the increase in wide release films occurring entirely in the third quarter. While the first half of fiscal 2024 compared to the first half of fiscal 2023 was comprised of a similar number of wide releases, there were fewer major franchise titles and an overall lower quality of film product during the first half of fiscal 2024, though film product quantity and quality significantly improved during the third quarter of fiscal 2024.
Our highest grossing films during the fiscal 2024 third quarter included Deadpool & Wolverine, Despicable Me 4, Twisters, Inside Out 2, and Beetlejuice Beetlejuice. Our top five films during our fiscal 2024 third quarter accounted for 66% of our total box office results, compared to 56% (including event cinema in both periods) for the top five films during the third quarter of fiscal 2023, both expressed as a percentage of the total admission revenues for the relevant period. An increased concentration of blockbuster films during a given quarter often has the effect of increasing our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. As a result of a more concentrated film slate, our overall film cost as a percentage of admission revenues increased during the third quarter of fiscal 2024 compared to the same period in the prior fiscal year.
Our average ticket price increased 2.6% during the third quarter of fiscal 2024, compared to the third quarter of fiscal 2023. During the first three quarters of fiscal 2024, our average ticket price increased 0.9% compared to the first three quarters of fiscal 2023. Our average ticket price during the third quarter of fiscal 2024 was positively impacted by an increased percentage of ticket sales coming from Premium Large Format (PLF) screens and evening showings, partially offset by the negative impact of an increased percentage of our weekly attendance coming from Value Tuesday, and promotional pricing offerings, including a $7 Everyday Matinee for seniors and children that was introduced during the second quarter of fiscal 2024. The overall change in average ticket price favorably impacted our admission revenues of our comparable theatres by $1.5 million and $0.9 million during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively.
Our average concession revenues per person increased by 7.9% and 3.7% during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively, due to market pricing adjustments, as well an increase in the number of concessions, food and beverage transactions per ticket sold, or our “hit rate”. During the second quarter of fiscal 2024, we made changes to our Value Tuesday promotion for our MMR loyalty members, discontinuing the prior promotion that offered a 20% discount on all concessions, food and non-alcoholic beverages and reintroducing a free complimentary-sized popcorn, which has been well received by guests. The overall increase in average concession revenues per person favorably impacted our concession revenues of our comparable theatres by $4.3 million and $4.6 million during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively.
Other revenues during the third quarter of fiscal 2024 increased by $3.7 million compared to the third quarter of fiscal 2023 due to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising revenue.
19
Late during the first quarter of fiscal 2024, we made changes to the criteria for waiving internet surcharge ticket fees for our MMR members, resulting in an increase in ticketing fees per person during the third quarter of fiscal 2024. Other revenues during the first three quarters of fiscal 2024 increased by $3.6 million compared to the first three quarters of fiscal 2023 due to an increase in internet surcharge ticketing fees per person, partially offset by the impact of overall decreased attendance on internet surcharge ticketing fees and preshow and in-app advertising revenue during the first three quarters of fiscal 2024.
The quantity, quality, and mix of films available for theatrical exhibition, including wide-release films, was negatively impacted during fiscal 2024 by the shutdown of movie production resulting from the WGA and SAG-AFTRA labor strikes that occurred during fiscal 2023. While the labor strikes were resolved in the fourth quarter of fiscal 2023 with film production resuming thereafter, the quantity of new film releases available for theatrical exhibition during fiscal 2024 was negatively impacted by the prolonged shutdown of movie production during the first half of the year, as was the overall quality of the films released, as several film release dates for major motion pictures were shifted to fiscal 2025. While lead times for movie production to theatrical release are lengthy, based upon projected film and alternate content availability, we currently estimate that we may once again show an increased number of films and alternate content events on our screens during fiscal 2025 compared to fiscal 2024.
We ended the third quarter of fiscal 2024 with a total of 981 company-owned screens in 78 theatres and 14 managed screens at one theatre, compared to 993 company-owned screens in 79 theatres at the end of the third quarter of fiscal 2023. We made decisions to close several underperforming theatres during fiscal 2023 and fiscal 2024, including one of our owned theatres in the first quarter of fiscal 2023, two owned theatres in the second quarter of fiscal 2023, two owned theatres and one leased theatre in the third quarter of fiscal 2023, and one leased theatre in the second quarter of fiscal 2024. During the third quarter of fiscal 2024, we added one theatre that we manage for the owner of a lifestyle shopping center.
Hotels and Resorts
The following table sets forth revenues, operating income and operating margin for our hotels and resorts division for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for variance percentage and operating margin):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct.F2024F2023Amt.Pct.
Revenues$88.7 $82.1 $6.6 8.1 %$220.4 $208.0 $12.5 6.0 %
Operating income17.0 14.4 2.7 18.5 %18.0 15.5 2.5 16.5 %
Operating margin (% of revenues)19.2 %17.5 % 8.2 %7.4 % 
Hotels and resorts revenues increased 8.1% and 6.0% during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively. Revenues were favorably impacted by approximately $3.3 million from the Republican National Convention (RNC) held in Milwaukee, Wisconsin during the third quarter of fiscal 2024. Our hotels and resorts division operating income increased $2.7 million and $2.5 million during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively, primarily due to an increase in revenue from the RNC during the third quarter of fiscal 2024, partially offset by an increase in depreciation expense from hotel renovations placed in service during fiscal 2023 and 2024.

20
The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for variance percentage):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct.F2024F2023Amt.Pct.
Room revenues$40.0 $36.5 $3.6 9.8 %$88.7 $83.0 $5.8 7.0 %
Food/beverage revenues22.3 20.2 2.1 10.2 %57.7 54.0 3.7 6.9 %
Other revenues16.7 15.4 1.3 8.1 %44.3 41.9 2.5 5.9 %
Total revenues before cost reimbursements79.0 72.1 6.9 9.6 %190.8 178.8 12.0 6.7 %
Cost reimbursements9.7 10.0 (0.2)(2.5)%29.6 29.2 0.5 1.6 %
Total revenues$88.7 $82.1 $6.6 8.1 %$220.4 $208.0 $12.5 6.0 %
Division total revenues before cost reimbursements increased 9.6% and 6.7% during the third quarter and first three quarters of fiscal 2024 compared to the third quarter and first three quarters of fiscal 2023, respectively, due primarily to an increase in group business revenues (including from the RNC) that offset lower weekend leisure travel demand. The increase in group business in fiscal 2024 has resulted in an increase in banquet and catering sales, positively impacting food and beverage revenues compared to the fiscal 2023 periods.
The following table sets forth certain operating statistics for the third quarter and first three quarters of fiscal 2024 and fiscal 2023, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for comparable company-owned properties:
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct. F2024F2023Amt.Pct.
Occupancy pct.76.7 %76.5 %0.2 pts0.3 %67.7 %65.2 %2.5 pts3.8 %
ADR$233.41 $213.05 $20.36 9.6 %$194.79 $189.09 $5.70 3.0 %
RevPAR$178.94 $163.00 $15.94 9.8 %$131.84 $123.23 $8.61 7.0 %
Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort.
RevPAR increased at four of our seven comparable company-owned properties during the third quarter of fiscal 2024 compared to the third quarter of fiscal 2023 driven primarily by the impact of high daily rates during the RNC during our fiscal 2024 third quarter. Excluding the impact of the RNC, average daily rates during the third quarter of fiscal 2024 were effectively flat compared to the third quarter of fiscal 2023. Group demand continued to grow during the fiscal 2024 third quarter, with weekday occupancy growth due to increased group business as a percentage of our overall business mix. During the third quarter of fiscal 2024, our group business represented approximately 47.3% of our total rooms revenue (43.1% excluding group business from the RNC), compared to approximately 40.7% during the third quarter of fiscal 2023. Excluding the positive impact of group business associated with the RNC, an increase in group business as a percentage of our overall business mix generally increases overall occupancy while negatively impacting ADR. Non-group pricing decreased in some of our major markets during the third quarter of fiscal 2024, due to generally lower transient leisure travel demand and due to a shift in pricing strategy as we optimized pricing to drive higher occupancy and overall RevPAR through lower daily rate offerings.
According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal 2024 third quarter and first three quarters results, comparable “upper upscale” hotels—hotels identified as our industry— throughout the United States experienced an increase in RevPAR of 1.4% during our fiscal 2024 third quarter compared to the same period during fiscal 2023, leading us to believe we outperformed the industry during the fiscal 2024 third quarter by approximately 8.4 percentage points. During the first three quarters of fiscal 2024 compared to the first three quarters of fiscal 2023, comparable “upper upscale” hotels experienced an increase in RevPAR of 2.1%, leading us to believe we outperformed the industry during the first three quarters of fiscal 2024 by 4.9 percentage points. We believe our
21
outperformance during the third quarter and first three quarters of fiscal 2024 results primarily from our strong performance in the group customer segment, incremental revenue from the RNC, as well as improved revenue management and rate optimization resulting in higher occupancy growth compared to the rest of the industry.
Data received from Smith Travel Research for our various “competitive sets”—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced an increase in RevPAR of 12.4% during our fiscal 2024 third quarter, again compared to the same period in fiscal 2023. Therefore, we underperformed our competitive sets during the third quarter of fiscal 2024 by approximately 2.6 percentage points. During the first three quarters of fiscal 2024 compared to the first three quarters of fiscal 2023, hotels in our competitive sets experienced an increase in RevPAR of 7.6%, indicating that we underperformed our competitive set hotels by approximately 0.6 percentage points. We believe our underperformance to our competitive sets during the third quarter and first three quarters of fiscal 2024 results from our mix of RNC business and airline crew business compared to our competitive sets, as well as new hotel room supply within one of our markets.
Looking to future periods, overall occupancy in the U.S. is expected to continue to slowly increase. In the near term, we expect leisure travel demand to continue to normalize to long-term historical demand levels, and we expect our group business to remain strong. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder in our primarily Midwestern markets. We expect gradual increases in business travel as corporate training events, meetings, and conferences return and office occupancy increases. As of the date of this report, our group room revenue bookings for the remainder of fiscal 2024 - commonly referred to in the hotels and resorts industry as “group pace” - is running approximately 11% ahead of where we were at the same time last year. Group room revenue bookings for fiscal 2025 is running over 30% ahead of where we were at the same time in fiscal 2023 for fiscal 2024, excluding bookings related to the July 2024 RNC. Banquet and catering revenue pace for fiscal 2024 and fiscal 2025 is similarly running ahead of where we were at this same time last year, excluding bookings related to the July 2024 Republican National Convention in Milwaukee. We are encouraged by continuing positive trends in group bookings for the remainder of fiscal 2024, fiscal 2025 and beyond.
Adjusted EBITDA
Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.
Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.
We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, impairment charges, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes, depreciation and amortization and non-cash share-based compensation expense, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.
22
The following table sets forth Adjusted EBITDA by reportable operating segment for the third quarter and first three quarters of fiscal 2024 and fiscal 2023 (in millions, except for variance percentage):
Third QuarterFirst Three Quarters
VarianceVariance
F2024F2023Amt.Pct. F2024F2023Amt.Pct.
Theatres$33.2 $26.7 $6.5 24.3 %$54.4 $71.7 $(17.3)(24.2)%
Hotels and resorts23.1 19.4 3.6 18.7 %34.5 30.4 4.1 13.6 %
Corporate items(4.0)(3.8)(0.2)(4.6)%(12.4)(11.6)(0.7)(6.4)%
Total Adjusted EBITDA$52.3 $42.3 $9.9 23.5 %$76.5 $90.5 $(14.0)(15.4)%

The following table sets forth our reconciliation of Adjusted EBITDA (in millions):
Third QuarterFirst Three Quarters
F2024F2023F2024F2023
Net earnings (loss)$23.3 $12.2 $(8.8)$16.2 
Add (deduct):
Investment (income) loss(0.8)(0.4)(1.7)(1.1)
Interest expense3.1 2.9 8.2 9.0 
Other (income) expense0.4 0.5 1.1 1.4 
Loss (gain) on disposition of property, equipment and other assets0.1 0.2 0.1 1.0 
Equity (earnings) losses from unconsolidated joint ventures— (0.1)0.4 0.1 
Income tax expense (benefit)5.4 5.9 3.8 7.1 
Depreciation and amortization17.3 19.2 50.0 51.0 
Share-based compensation expenses (1)
2.2 1.3 7.2 5.0 
Impairment charges (2)
— 0.7 0.5 0.7 
Theatre exit costs (3)
— — 0.1 — 
Insured losses (recoveries) (4)
(0.2)— 0.2 — 
Debt conversion expense (5)
1.4 — 15.3 — 
Other non-recurring (6)
0.1 — 0.1 — 
Total Adjusted EBITDA$52.3 $42.3 $76.5 $90.5 
The following tables sets forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):
Third Quarter, F2024First Three Quarters, F2024
TheatresHotels & ResortsCorp. ItemsTotalTheatresHotels & ResortsCorp. ItemsTotal
Operating income (loss)$21.8 $17.0 $(6.0)$32.8 $18.8 $18.0 $(18.4)$18.4 
Depreciation and amortization11.3 5.8 0.1 17.3 33.9 15.7 0.4 50.0 
Loss (gain) on disposition of property, equipment and other assets0.1 — — 0.1 0.1 — — 0.1 
Share-based compensation (1)
0.2 0.3 1.8 2.2 0.8 0.8 5.6 7.2 
Impairment charges (2)
— — — — 0.5 — — 0.5 
Theatre exit costs (3)
— — — — 0.1 — — 0.1 
Insured losses (recoveries) (4)
(0.2)— — (0.2)0.2 — — 0.2 
Other non-recurring (6)
— — 0.1 0.1 — — 0.1 0.1 
Total Adjusted EBITDA$33.2 $23.1 $(4.0)$52.3 $54.4 $34.5 $(12.4)$76.5 
23
Third Quarter, F2023First Three Quarters, F2023
TheatresHotels & ResortsCorp. ItemsTotalTheatresHotels & ResortsCorp. ItemsTotal
Operating income (loss)$11.4 $14.4 $(4.8)$20.9 $32.7 $15.5 $(15.4)$32.8 
Depreciation and amortization14.3 4.8 0.1 19.2 37.1 13.7 0.3 51.0 
Loss (gain) on disposition of property, equipment and other assets0.2 — — 0.2 0.5 0.5 — 1.0 
Share-based compensation (1)
0.1 0.2 0.9 1.3 0.8 0.7 3.5 5.0 
Impairment charges (2)
0.7 — — 0.7 0.7 — — 0.7 
Total Adjusted EBITDA$26.7 $19.4 $(3.8)$42.3 $71.7 $30.4 $(11.6)$90.5 
(1)Non-cash expense related to share-based compensation programs.
(2)Non-cash impairment charges related to one permanently closed theatre location in the second quarter of fiscal 2024 and one permanently closed theatre location in fiscal 2023.
(3)Reflects non-recurring costs related to the closure and exit of one theatre location in the second quarter of fiscal 2024.
(4)Repair costs and insurance recoveries related to insured property damage at one theatre location that are non-operating in nature.
(5)Debt conversion expense resulting from repurchases of $99.9 million aggregate principal amount of Convertible Notes. See Convertible Senior Notes Repurchases in the “Liquidity and Capital Resources” section of this MD&A for further discussion.
(6)Other non-recurring includes professional fees related to convertible debt repurchase transactions.

LIQUIDITY AND CAPITAL RESOURCES
Liquidity
Our movie theatre and hotels and resorts businesses each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment’s revenue is derived predominantly from consumer cash purchases. We believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses.
Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our 89-year history and our financial position remains strong. As of September 26, 2024, we had a cash balance of approximately $28.4 million, $220.2 million of availability under our $225 million revolving credit facility, our debt-to-capitalization ratio was 0.27, and our net leverage ratio was 1.67x net debt to Adjusted EBITDA. With our strong liquidity position combined with cash generated from operations, we believe we have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial statements, as well as fund our longer-term capital requirements.
24
The following table sets forth our reconciliations of Net Debt and Net Leverage (Net Debt to Adjusted EBITDA) (in millions, except leverage ratio):
September 26, 2024December 28, 2023
Long-term debt (GAAP measure) (1)
$173.1 $169.9 
Finance lease obligations (GAAP measure) (2)
13.5 15.3 
Less: Cash and cash equivalents(28.4)(55.6)
Net Debt$158.2 $129.6 
Net Debt$158.2 $129.6 
LTM Adjusted EBITDA (3)
94.8 108.7 
Net Leverage (Net Debt to Adjusted EBITDA)1.67x1.19x
(1)Represents total long-term debt, including the current portion of long-term debt.
(2)Represents total finance lease obligations, including the current portion of finance lease obligations.
(3)LTM Adjusted EBITDA is Adjusted EBITDA as reconciled and defined above for the last four fiscal quarters.

We believe Net Leverage is a useful measure, as it provides management and investors an indication of our indebtedness less unrestricted cash relative to our earnings performance.
Financial Condition
Net cash provided by operating activities totaled $51.4 million during the first three quarters of fiscal 2024, compared to net cash provided by operating activities of $68.6 million during the first three quarters of fiscal 2023. The $17.3 million decrease in net cash used in operating activities was primarily due to a $25.0 million decrease in net earnings, a $1.3 million increase in cash matching contributions to our retirement savings and profit-sharing plan, a decrease in deferred income tax benefits and unfavorable changes in working capital, partially offset by a $15.3 million non-cash debt conversion expense and an increase in non-cash share-based compensation expense.
Net cash used in investing activities during the first three quarters of fiscal 2024 totaled $58.4 million, compared to net cash used in investing activities of $26.9 million during the first three quarters of fiscal 2023. The increase in net cash used in investing activities of $31.5 million was the result of an increase of $27.9 million in capital expenditures, and a $5.6 million purchase of joint venture interests in The Lofton Hotel, partially offset by a $1.5 million sale of joint venture interests in The Lofton Hotel to other minority investors. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled $53.8 million during the first three quarters of fiscal 2024 compared to $25.8 million during the first three quarters of fiscal 2023.
Fiscal 2024 first three quarters cash capital expenditures included approximately $11.4 million incurred in our theatre division, primarily related to normal maintenance capital projects. We incurred capital expenditures in our hotels and resorts division during the first three quarters of fiscal 2024 of approximately $36.6 million, including costs related to guest room renovations at The Pfister Hotel, associate housing construction and meeting space renovations at the Grand Geneva Resort and Spa and normal maintenance capital projects. We incurred corporate capital expenditures during the first three quarters of fiscal 2024 of approximately $5.8 million primarily related to office construction for the relocation of our corporate and divisional headquarters (a portion of which will be reimbursed by the landlord in a future period).
Net cash used in financing activities during the first three quarters of fiscal 2024 totaled $19.8 million compared to net cash used in financing activities of $26.2 million during the first three quarters of fiscal 2023. During the first three quarters of fiscal 2024, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added $81.0 million of new short-term revolving credit facility borrowings, and we made $81.0 million of repayments on short-term revolving credit facility borrowings during the first three quarters of fiscal 2024 (net zero borrowings on our credit facility). We ended the third quarter of fiscal 2024 with no outstanding borrowings under our revolving credit facility.
25
During the first three quarters of fiscal 2023, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added $38.0 million of new short-term revolving credit facility borrowings, and we made $38.0 million of repayments on short-term revolving credit facility borrowings during the first three quarters of fiscal 2023 (net zero borrowings on our credit facility).
Principal payments on long-term debt were approximately $11.0 million during the first three quarters of fiscal 2024 compared to payments of $11.1 million during the first three quarters of fiscal 2023.
During the first three quarters of fiscal 2024 we received $100.0 million of cash proceeds from the issuance of senior notes in July 2024. See Master Note Purchase Agreement for further discussion below.
During the first three quarters of fiscal 2024 we paid $102.5 million in cash for the Convertible Notes Repurchases (as defined below) and related transaction costs, with no repurchases in fiscal 2023. We received $13.2 million in cash from the proportionate unwind of the Capped Call Transactions in connection with the Convertible Notes Repurchases during the first three quarters of fiscal 2024. See Convertible Senior Notes Repurchases for further discussion below.
Our debt-to-capitalization ratio (excluding our finance and operating lease obligations) was 0.27 at September 26, 2024, compared to 0.26 at December 28, 2023.
During the first three quarters of fiscal 2024, we repurchased 0.7 million shares of our common stock for $9.7 million in the open market, compared to no share repurchases of our common stock in the open market during the first three quarters of fiscal 2023. As of September 26, 2024, approximately 1.7 million shares remained available for repurchase under prior Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.
Dividends paid during the first three quarters of fiscal 2024 were $6.6 million. Dividends paid during the first three quarters of fiscal 2023 were $5.3 million. We have the ability to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.
Convertible Senior Notes Repurchases
During the first three quarters of fiscal 2024, we entered into separate, privately negotiated purchase agreements (the “Purchase Agreements”) with certain holders of its Convertible Notes. Under the terms of the Purchase Agreements, the holders agreed to exchange $99.9 million in aggregate principal amount of Convertible Notes for cash consideration of $121.5 million (or $103.3 million net of the cash we received in connection with the unwind of a portion of the Capped Call Transactions as discussed below) effected over three separate repurchase tranches (the “Convertible Notes Repurchases”). On May 8, 2024, we entered into the first repurchase transaction to retire $40.0 million of aggregate principal amount of Convertible Notes for $45.9 million in cash consideration plus accrued interest, with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, we entered into the second repurchase transaction to retire $46.4 million of aggregate principal amount of Convertible Notes for $55.2 million in cash consideration plus accrued interest, with settlement occurring during the fiscal third quarter on July 16, 2024. On September 19, 2024, we entered into the third repurchase transaction to retire $13.5 million of aggregate principal amount of Convertible Notes for $20.4 million in cash consideration plus accrued interest, with settlement occurring during the fiscal fourth quarter on October 11, 2024. Following settlement of the Convertible Note Repurchases on October 11, 2024, the aggregate principal amount of Convertible Notes outstanding was $0.1 million.
In connection with the Convertible Notes Repurchases, we entered into unwind agreements with the Capped Call Counterparties to terminate a portion of the Capped Call Transactions equal to the notional amounts of the Convertible Notes Repurchases, and to receive aggregate cash of $18.2 million effected over two separate unwind tranches. On May 8, 2024, we entered into the first tranche of unwind agreements and received $5.8 million in cash consideration with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, we entered into the second tranche of unwind agreements and received $7.5 million in cash consideration at settlement occurring during the fiscal third quarter on July 16, 2024.
During the third quarter and first three quarters of fiscal 2024, we incurred debt conversion expense of $1.4 million and $15.3 million, respectively, in connection with the Convertible Notes Repurchases. The unwind of the Capped Call
26
Transactions resulted in a $4.7 million and $17.6 million increase in capital in excess of par within shareholders’ equity during the third quarter and first three quarters of fiscal 2024, respectively.
Master Note Purchase Agreement
During the third quarter of fiscal 2024, on July 9, 2024, we entered into a Master Note Purchase Agreement with several purchasers party to the agreement, pursuant to which we issued and sold $100.0 million aggregate principal amount of senior notes in two tranches: (i) $60.0 million in aggregate principal amount of the Company’s 6.89% Series 2024 Senior Notes, Tranche A due July 9, 2031 (the “Tranche A Notes”) and (ii) $40.0 million in aggregate principal amount of the Company’s 7.02% Series 2024 Senior Notes, Tranche B due July 9, 2034 (the “Tranche B Notes” and, collectively with the Tranche A Notes, the “2024 Senior Notes”). The net proceeds were used to refinance the Convertible Notes Repurchases of $99.9 million aggregate principal amount of Convertible Notes and for general corporate purposes.
Interest on the 2024 Senior Notes is payable semi-annually in arrears on the 9th day of January and July each year, commencing on January 9, 2025, and on the applicable maturity date. The Tranche A Notes require annual principal amortization payments beginning in fiscal 2027 with a final maturity in fiscal 2031. The Tranche B Notes require annual principal amortization payments beginning in fiscal 2028 with a final maturity in fiscal 2034. The Master Note Purchase Agreement contains various restrictions and covenants applicable to the Company and certain of its subsidiaries that are consistent with the restrictions, covenants and collateral provisions in the Company’s existing Credit Agreement and Note Purchase Agreements. Among other requirements, the Master Note Purchase Agreement requires us to maintain (i) a ratio of consolidated net debt (as defined in the Master Note Purchase Agreement) to consolidated EBITDA (as defined in the Master Note Purchase Agreement) of 3.50 to 1.00 or less, with some temporary exceptions for material acquisitions, and (ii) a minimum ratio of consolidated EBITDA to consolidated interest expense (as defined in the Master Note Purchase Agreement) for each period of four consecutive fiscal quarters (determined as of the last day of each fiscal quarter) of 3.00 to 1.00 or more.
Critical Accounting Policies and Estimates
We have included a summary of our Critical Accounting Policies and Estimates in our Annual Report on Form 10-K for the year ended December 28, 2023. There have been no material changes to the summary provided in that report.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
We have not experienced any material changes in our market risk exposures since December 28, 2023.
Item 4. Controls and Procedures
a.Evaluation of disclosure controls and procedures
Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.
b.Changes in internal control over financial reporting
There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
27
PART II – OTHER INFORMATION
Item 1A. Risk Factors
There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 28, 2023.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.
PeriodTotal Number of
Shares
Purchased		Average Price
Paid per Share		Total Number of
Shares
Purchased as
Part of Publicly
Announced
Programs (1)		Maximum
Number of
Shares that May
Yet be Purchased
Under the Plans
or Programs (1)
June 28 - August 153 $11.31 53 2,407,548 
August 2 - August 29321,871 13.39 321,871 2,085,677 
August 30 - September 26370,978 14.40 370,978 1,714,699 
  Total692,902 $13.93 692,902 1,714,699 
(1)Through September 26, 2024, our Board of Directors had authorized the repurchase of up to approximately 11.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of September 26, 2024, we had repurchased approximately 10.0 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit, option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date. The shares purchased during the first quarter of 2024 were purchased in connection with the vesting of grants of restricted stock in which we repurchased shares from the stockholders whose restricted shares vested in order to cover such stockholders’ related withholding taxes.
Item 4. Mine Safety Disclosures
Not applicable.

Item 5. Other Information

During the thirteen weeks ended September 26, 2024, no director or Section 16 officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
28
Item 6. Exhibits
4.1
31.1
31.2
32
101.INSThe instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.
101.SCHInline XBRL Taxonomy Extension Schema Document.
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
29
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
THE MARCUS CORPORATION
DATE: October 31, 2024
By: /s/ Gregory S. Marcus
Gregory S. Marcus
President and Chief Executive Officer
DATE: October 31, 2024
By: /s/ Chad M. Paris
Chad M. Paris
Chief Financial Officer and Treasurer
S-1

Exhibit 31.1
Certification of Chief Executive Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)
or 15d-14(a) under the Securities Exchange Act of 1934
I, Gregory S. Marcus, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
DATE: October 31, 2024
By:/s/ Gregory S. Marcus
Gregory S. Marcus
President and Chief Executive Officer


Exhibit 31.2
Certification of Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)
or 15d-14(a) under the Securities Exchange Act of 1934
I, Chad M. Paris, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
DATE: October 31, 2024
By:/s/ Chad M. Paris
Chad M. Paris
Chief Financial Officer and Treasurer


Exhibit 32
Written Statement of the Chief Executive Officer and Chief Financial Officer
Pursuant to 18 U.S.C. §1350
Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of The Marcus Corporation (the “Company”), hereby certify, based on our knowledge, that the accompanying Quarterly Report on Form 10-Q of the Company (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Gregory S. Marcus
Gregory S. Marcus
President and Chief Executive Officer
/s/ Chad M. Paris
Chad M. Paris
Chief Financial Officer and Treasurer
Date:October 31, 2024

v3.24.3
Cover - shares
 9 Months Ended
Sep. 26, 2024
Oct. 29, 2024
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 26, 2024  
Document Transition Report false  
Entity File Number 1-12604  
Entity Registrant Name MARCUS CORP  
Entity Incorporation, State or Country Code WI  
Entity Tax Identification Number 39-1139844  
Entity Address, Address Line One 111 East Kilbourn Avenue  
Entity Address, Address Line Two Suite 1200  
Entity Address, City or Town Milwaukee  
Entity Address, State or Province WI  
Entity Address, Postal Zip Code 53202-6628  
City Area Code 414  
Local Phone Number 905-1000  
Title of 12(b) Security Common Stock, $1.00 par value  
Trading Symbol MCS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Central Index Key 0000062234  
Current Fiscal Year End Date --12-26  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q3  
Amendment Flag false  
Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   24,497,446
Class B Common Stock    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   6,984,584
v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 26, 2024
Dec. 28, 2023
Current assets:    
Cash and cash equivalents $ 28,415 $ 55,589
Restricted cash 4,630 4,249
Accounts receivable, net of reserves of $176 and $115, respectively 28,309 19,703
Other current assets 26,391 22,175
Total current assets 87,745 101,716
Property and equipment:    
Land and improvements 132,236 131,833
Buildings and improvements 733,972 719,521
Leasehold improvements 163,891 166,245
Furniture, fixtures and equipment 422,296 397,150
Finance lease right-of-use assets 29,219 30,106
Construction in progress 17,551 11,432
Total property and equipment 1,499,165 1,456,287
Less accumulated depreciation and amortization 812,172 774,025
Net property and equipment 686,993 682,262
Operating lease right-of-use assets 168,404 179,788
Other assets:    
Investments in joint ventures 5,392 1,718
Goodwill 74,996 74,996
Other 23,429 24,623
Total other assets 103,817 101,337
TOTAL ASSETS 1,046,959 1,065,103
Current liabilities:    
Accounts payable 39,284 37,384
Income taxes 847 0
Taxes other than income taxes 17,730 18,585
Accrued compensation 17,386 22,598
Other accrued liabilities 58,931 57,685
Current portion of finance lease obligations 2,546 2,579
Current portion of operating lease obligations 14,315 15,290
Current maturities of long-term debt 10,460 10,303
Total current liabilities 161,499 164,424
Finance lease obligations 10,989 12,753
Operating lease obligations 167,384 178,582
Long-term debt 162,633 159,548
Deferred income taxes 34,719 32,235
Other long-term obligations 47,443 46,389
Shareholders’ Equity:    
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued 0 0
Capital in excess of par 176,198 160,642
Retained earnings 266,211 281,599
Accumulated other comprehensive loss (1,371) (1,336)
Stockholders' equity before treasury stock 473,260 472,675
Less cost of Common Stock in treasury (739,977 shares at September 26, 2024 and 47,916 shares at December 28, 2023) (10,968) (1,503)
Total shareholders’ equity 462,292 471,172
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY 1,046,959 1,065,103
Common Stock    
Shareholders’ Equity:    
Common Stock 25,237 24,692
Class B Common Stock    
Shareholders’ Equity:    
Common Stock $ 6,985 $ 7,078
v3.24.3
Consolidated Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 26, 2024
Dec. 28, 2023
Accounts receivables $ 176 $ 115
Preferred stock, par (in dollars per share) $ 1 $ 1
Preferred stock, authorized (in shares) 1,000,000 1,000,000
Preferred stock, issued (in shares) 0 0
Cost of common stock in treasury (in shares) 739,977 47,916
Common Stock    
Common stock, par (in dollars per share) $ 1 $ 1
Common stock, authorized (in shares) 50,000,000 50,000,000
Common stock, issued (in shares) 25,237,374 24,691,548
Class B Common Stock    
Common stock, par (in dollars per share) $ 1 $ 1
Common stock, authorized (in shares) 33,000,000 33,000,000
Common stock, issued (in shares) 6,984,584 7,078,410
Common stock, outstanding (in shares) 6,984,584 7,078,410
v3.24.3
Consolidated Statements of Earnings (Loss) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Revenues:        
Revenues other than cost reimbursements $ 222,276 $ 198,781 $ 516,944 $ 538,870
Cost reimbursements 10,392 9,985 30,303 29,179
Total revenues 232,668 208,766 547,247 568,049
Costs and expenses:        
Advertising and marketing 6,645 6,025 18,448 16,703
Administrative 23,202 19,854 67,234 59,171
Depreciation and amortization 17,274 19,158 49,988 51,028
Rent 6,631 6,592 19,474 19,679
Property taxes 4,442 4,663 12,061 13,952
Other operating expenses 10,279 10,290 29,890 29,577
Loss on disposition of property, equipment and other assets 115 242 95 1,019
Impairment charges 0 684 472 684
Reimbursed costs 10,392 9,985 30,303 29,179
Total costs and expenses 199,886 187,833 528,893 535,294
Operating income 32,782 20,933 18,354 32,755
Other income (expense):        
Investment income 809 445 1,674 1,064
Interest expense (3,062) (2,869) (8,160) (8,970)
Other income (expense) (390) (477) (1,121) (1,355)
Debt conversion expense (1,410) 0 (15,318) 0
Equity earnings (losses) from unconsolidated joint ventures (9) 75 (446) (127)
Nonoperating income (expense), total (4,062) (2,826) (23,371) (9,388)
Earnings (loss) before income taxes 28,720 18,107 (5,017) 23,367
Income tax expense 5,406 5,873 3,756 7,133
Net earnings (loss) $ 23,314 $ 12,234 $ (8,773) $ 16,234
Common Stock        
Net earnings (loss) per share - basic:        
Net earnings (loss) per share - basic (in dollars per share) $ 0.74 $ 0.39 $ (0.28) $ 0.52
Net earnings (loss) per share - diluted:        
Net earnings (loss) per share - diluted (in dollars per share) 0.73 0.32 (0.28) 0.46
Class B Common Stock        
Net earnings (loss) per share - basic:        
Net earnings (loss) per share - basic (in dollars per share) 0.69 0.36 (0.26) 0.48
Net earnings (loss) per share - diluted:        
Net earnings (loss) per share - diluted (in dollars per share) $ 0.69 $ 0.31 $ (0.26) $ 0.46
Theatre admissions        
Revenues:        
Revenues $ 68,980 $ 63,652 $ 158,156 $ 180,274
Rooms        
Revenues:        
Revenues 40,019 36,456 88,728 82,959
Costs and expenses:        
Costs 12,300 11,594 32,875 31,232
Theatre concessions        
Revenues:        
Revenues 62,118 54,551 141,230 156,633
Costs and expenses:        
Costs 24,062 20,738 57,463 59,069
Food and beverage        
Revenues:        
Revenues 22,283 20,214 57,718 53,980
Costs and expenses:        
Costs 16,084 15,266 45,027 43,285
Other revenues        
Revenues:        
Revenues 28,876 23,908 71,112 65,024
Theatre operations        
Costs and expenses:        
Costs $ 68,460 $ 62,742 $ 165,563 $ 180,716
v3.24.3
Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Statement of Comprehensive Income [Abstract]        
Net earnings (loss) $ 23,314 $ 12,234 $ (8,773) $ 16,234
Other comprehensive loss, net of tax:        
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax benefit of $4, $4, $13 and $13, respectively (12) (12) (35) (35)
Fair market value adjustment of interest rate swap, net of tax benefit of $8 0 0 0 (22)
Reclassification adjustment on interest rate swap included in interest expense, net of tax benefit of $20 0 0 0 (58)
Other comprehensive loss (12) (12) (35) (115)
Comprehensive income (loss) $ 23,302 $ 12,222 $ (8,808) $ 16,119
v3.24.3
Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Statement of Comprehensive Income [Abstract]        
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect (benefit) $ (4) $ (4) $ (13) $ (13)
Fair market value adjustment of interest rate swap, net of tax effect (benefit)       (8)
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect (benefit)       $ (20)
v3.24.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
OPERATING ACTIVITIES:    
Net earnings (loss) $ (8,773) $ 16,234
Adjustments to reconcile net loss to net cash used in operating activities:    
Losses on investments in joint ventures 446 127
Distribution from joint venture 0 200
(Gain) loss on disposition of property, equipment and other assets 95 1,019
Impairment charges 472 684
Debt conversion expense 15,318 0
Depreciation and amortization 49,988 51,028
Amortization of debt issuance costs 918 1,109
Share-based compensation 7,157 5,000
Deferred income taxes 2,496 6,586
Other long-term obligations 1,293 904
Contribution of the Company’s stock to savings and profit-sharing plan 0 1,259
Changes in operating assets and liabilities:    
Accounts receivable (3,851) 59
Other assets (175) (3,043)
Operating leases (541) (663)
Accounts payable (2,934) (4,389)
Income taxes 1,060 (241)
Taxes other than income taxes (855) 1,061
Accrued compensation (5,212) (6,195)
Other accrued liabilities (5,528) (2,097)
Total adjustments 60,147 52,408
Net cash provided by operating activities 51,374 68,642
INVESTING ACTIVITIES:    
Capital expenditures (53,770) (25,836)
Proceeds from disposals of property, equipment and other assets 151 67
Capital contribution in joint venture (5,620) 0
Subscription and sale of joint venture interests 1,500 0
Proceeds from sale of trading securities 37 17
Purchase of trading securities (1,148) (839)
Other investing activities 453 (291)
Net cash used in investing activities (58,397) (26,882)
Debt transactions:    
Proceeds from borrowings on revolving credit facility 81,000 38,000
Repayment of borrowings on revolving credit facility (81,000) (38,000)
Proceeds from issuance of long-term debt 100,000 0
Principal payments on long-term debt (11,024) (11,097)
Repayment of borrowing on insurance policy 0 (6,700)
Repurchase of convertible senior notes (102,525) 0
Proceeds from capped call unwind 13,230 0
Debt issuance costs (1,083) (82)
Principal payments on finance lease obligations (1,842) (1,904)
Equity transactions:    
Treasury stock transactions, except for stock options (9,911) (526)
Exercise of stock options 0 222
Dividends paid (6,615) (5,273)
Distributions to noncontrolling interest 0 (824)
Net cash used in financing activities (19,770) (26,184)
Net increase (decrease) in cash, cash equivalents and restricted cash (26,793) 15,576
Cash, cash equivalents and restricted cash at beginning of period 59,838 24,506
Cash, cash equivalents and restricted cash at end of period 33,045 40,082
Supplemental Information:    
Interest paid, net of amounts capitalized 8,630 9,542
Income taxes paid, including interest earned (201) (788)
Change in accounts payable for additions to property, equipment and other assets $ 4,834 $ 1,550
v3.24.3
General
 9 Months Ended
Sep. 26, 2024
Accounting Policies [Abstract]  
General General
Basis of Presentation - The unaudited consolidated financial statements for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at September 26, 2024, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 28, 2023.
Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 28, 2023, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.
Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $17,277 and $49,992 for the 13 and 39 weeks ended September 26, 2024, respectively, and $19,150 and $51,004 for the 13 and 39 weeks ended September 28, 2023, respectively.
Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset.
Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value.
During the 39 weeks ended September 26, 2024, the Company determined that indicators of impairment were present at one asset group for a leased theatre location that the Company made the decision to close during the second quarter of fiscal 2024. As such, the Company evaluated the fair value of these assets, consisting primarily of land improvements, leasehold improvements, building, furniture, fixtures and equipment, and operating lease right-of-use assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset), was less than their carrying values and recorded a $472 impairment loss, reducing certain property and equipment and certain operating lease net obligations. The remaining net book value of the impaired assets as of the date of the asset write-down (June 27, 2024) was $0.
During the 13 weeks ended September 28, 2023, the Company determined that indicators of impairment were present at one theatre asset group. As such, the Company evaluated the fair value of these assets, consisting primarily of land, building and furniture, fixtures and equipment, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $684 impairment loss, reducing certain property and equipment assets. The remaining net book value of the impaired assets as of the date of the asset write-down (September 28, 2023) was $3,040.
Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 39 weeks ended September 26, 2024 or September 28, 2023.
Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options, restricted stock units, performance stock units and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.
Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.
The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Net earnings (loss) per share - basic:
Common Stock$0.74 $0.39 $(0.28)$0.52 
Class B Common Stock$0.69 $0.36 $(0.26)$0.48 
Net earnings (loss) per share - diluted:
Common Stock$0.73 $0.32 $(0.28)$0.46 
Class B Common Stock$0.69 $0.31 $(0.26)$0.46 
Numerator:
Net earnings (loss) $23,314 $12,234 $(8,773)$16,234 
Denominator (in thousands):
Denominator for basic EPS31,953 31,691 32,002 31,645 
Effect of dilutive employee stock options17 41 — 48 
Effect of restricted stock units47 — — — 
Effect of convertible senior notes14 9,242 — 9,242 
Diluted weighted-average shares outstanding32,031 40,974 32,002 40,935 
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):
Employee stock options2,800 2,965 2,809 2,965 
Restricted stock units— — 49 — 
Performance stock units139 — 141 — 
Convertible senior notes— — 14 — 
Total2,939 2,965 3,013 2,965 
For the periods when the Company reports a net loss, common stock equivalents, restricted stock units, performance stock units, and shares related to the convertible senior notes are excluded from the computation of diluted loss per share as their inclusion would have an anti-dilutive effect. Performance stock units are considered anti-dilutive if the performance targets upon which the issuance of the shares are contingent have not been achieved and the respective performance period has not been completed as of the end of the current period. Shares related to the convertible senior notes are excluded from the computation of diluted earnings per share in periods when the effect would have been anti-dilutive using the if-converted method.
Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 39 weeks ended September 26, 2024 and September 28, 2023 was as follows:
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Total Shareholders’
Equity
BALANCES AT DECEMBER 28, 2023$24,692 $7,078 $160,642 $281,599 $(1,336)$(1,503)$471,172 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (449)— — (449)
$0.07 per share Common Stock
— — — (1,760)— — (1,760)
Purchase of treasury stock— — — — — (301)(301)
Reissuance of treasury stock— — (3)— — 23 20 
Issuance of non-vested stock452 — (515)— — 63 — 
Shared-based compensation— — 2,514 — — — 2,514 
Conversions of Class B Common Stock93 (93)— — — — — 
Comprehensive loss— — — (11,866)(12)— (11,878)
BALANCES AT MARCH 28, 202425,237 6,985 162,638 267,524 (1,348)(1,718)459,318 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.07 per share Common Stock
— — — (1,763)— — (1,763)
Reissuance of treasury stock— — (7)— — 23 16 
Issuance of non-vested stock— — (326)— — 326 — 
Shared-based compensation— — 2,418 — — — 2,418 
Convertible senior note repurchase— — (2,788)— — — (2,788)
Capped call unwind— — 12,904 — — — 12,904 
Comprehensive loss— — — (20,221)(11)— (20,232)
BALANCES AT JUNE 27, 202425,237 6,985 174,839 245,093 (1,359)(1,369)449,426 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.070 per share Common Stock
— — — (1,749)— — (1,749)
Purchase of treasury stock— — — — — (9,667)(9,667)
Reissuance of treasury stock— — 6 — — 16 22 
Issuance of non-vested stock— — (52)— — 52 — 
Shared-based compensation— — 2,225 — — — 2,225 
Convertible senior note repurchase— — (5,472)— — — (5,472)
Capped call unwind— — 4,652 — — — 4,652 
Comprehensive income — — — 23,314 (12)— 23,302 
BALANCES AT SEPTEMBER 26, 2024$25,237 $6,985 $176,198 $266,211 $(1,371)$(10,968)$462,292 
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Shareholders’
Equity
Attributable
to The
Marcus
Corporation		Non-
controlling
Interest		Total
Equity
BALANCES AT DECEMBER 29, 2022$24,498 $7,111 $153,794 $274,254 $(1,694)$(1,866)$456,097 $824 $456,921 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,229)— — (1,229)— (1,229)
Exercise of stock options— — (1)— — 3 2 — 2 
Purchase of treasury stock— — — — — (313)(313)— (313)
Savings and profit-sharing contribution79 — 1,180 — — — 1,259 — 1,259 
Reissuance of treasury stock— — (3)— — 24 21 — 21 
Issuance of non-vested stock82 — (143)— — 61 — — — 
Shared-based compensation— — 2,172 — — — 2,172 — 2,172 
Other— — 1 (1)— — — — — 
Conversions of Class B Common Stock33 (33)— — — — — — — 
Distribution to noncontrolling interest— — — — — — — (550)(550)
Comprehensive loss— — — (9,466)(91)— (9,557)— (9,557)
BALANCES AT MARCH 30, 202324,692 7,078 157,000 263,239 (1,785)(2,091)448,133 274 448,407 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,230)— — (1,230)— (1,230)
Exercise of stock options— — (25)— — 121 96 — 96 
Purchase of treasury stock— — — — — (226)(226)— (226)
Reissuance of treasury stock— — (204)— — 223 19 — 19 
Issuance of non-vested stock— — (55)— — 55 — — — 
Shared-based compensation— — 1,515 — — — 1,515 — 1,515 
Other— — — 1 — (1)— — — 
Distribution to noncontrolling interest— — — — — — — (274)(274)
Comprehensive income (loss)— — — 13,466 (12)— 13,454 — 13,454 
BALANCES AT JUNE 29, 202324,692 7,078 158,231 275,157 (1,797)(1,919)461,442 — 461,442 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (453)— — (453)— (453)
$0.07 per share Common Stock
— — — (1,723)— — (1,723)— (1,723)
Exercise of stock options— — (184)— — 1,171 987 — 987 
Purchase of treasury stock— — — — — (914)(914)— (914)
Reissuance of treasury stock— — (3)— — 27 24 — 24 
Issuance of non-vested stock— — (53)— — 53 — — — 
Shared-based compensation— — 1,313 — — — 1,313 — 1,313 
Comprehensive income — — — 12,234 (12)— 12,222 — 12,222 
BALANCES AT SEPTEMBER 28, 2023$24,692 $7,078 $159,304 $285,215 $(1,809)$(1,582)$472,898 $— $472,898 

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
September 26,
2024		December 28,
2023
Net unrecognized actuarial loss for pension obligation$(1,371)$(1,336)
$(1,371)$(1,336)
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.
The Company’s assets and liabilities measured at fair value are classified in one of the following categories:
Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At September 26, 2024 and December 28, 2023, the Company’s $7,332 and $5,364 respectively, of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At September 26, 2024 and December 28, 2023, the Company’s $15,014 and $37,018, respectively, of investments in money market funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents.
Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities were measured using Level 2 pricing inputs.
Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets that are measured on a non-recurring basis are discussed above under Long-Lived Assets.
The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $160,000 of senior notes, valued using Level 2 pricing inputs, is approximately $160,917 at September 26, 2024, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $13,649 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $20,183 at September 26, 2024, determined based on market rates and the closing trading price of the convertible senior notes as of September 26, 2024. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.
Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Service cost$62 $122 $186 $366 
Interest cost445 453 1,334 1,358 
Net amortization of prior service cost and actuarial loss(16)(16)(48)(48)
Net periodic pension cost$491 $559 $1,472 $1,676 
Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.
Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 26, 2024 is as follows:
13 Weeks Ended September 26, 2024
TheatresHotels/Resorts CorporateTotal
Theatre admissions$68,980 $— $— $68,980 
Rooms— 40,019 — 40,019 
Theatre concessions62,118 — — 62,118 
Food and beverage— 22,283 — 22,283 
Other revenues(1)
12,090 16,699 87 28,876 
  Revenue before cost reimbursements143,188 79,001 87 222,276 
Cost reimbursements655 9,737 — 10,392 
Total revenues$143,843 $88,738 $87 $232,668 
39 Weeks Ended September 26, 2024
TheatresHotels/ResortsCorporateTotal
Theatre admissions$158,156 $— $— $158,156 
Rooms— 88,728 — 88,728 
Theatre concessions141,230 — — 141,230 
Food and beverage— 57,718 — 57,718 
Other revenues(1)
26,524 44,338 250 71,112 
  Revenue before cost reimbursements325,910 190,784 250 516,944 
Cost reimbursements655 29,648 — 30,303 
Total revenues$326,565 $220,432 $250 $547,247 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 28, 2023 is as follows:
13 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$63,652 $— $— $63,652 
Rooms— 36,456 — 36,456 
Theatre concessions54,551 — — 54,551 
Food and beverage— 20,214 — 20,214 
Other revenues(1)
8,382 15,443 83 23,908 
  Revenue before cost reimbursements126,585 72,113 83 198,781 
Cost reimbursements— 9,985 — 9,985 
Total revenues$126,585 $82,098 $83 $208,766 
39 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$180,274 $— $— $180,274 
Rooms— 82,959 — 82,959 
Theatre concessions156,633 — — 156,633 
Food and beverage— 53,980 — 53,980 
Other revenues(1)
22,904 41,857 263 65,024 
  Revenue before cost reimbursements359,811 178,796 263 538,870 
Cost reimbursements— 29,179 — 29,179 
Total revenues$359,811 $207,975 $263 $568,049 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The Company had deferred revenue from contracts with customers of $34,463 and $38,034 as of September 26, 2024 and December 28, 2023, respectively. The Company had no contract assets as of September 26, 2024 and December 28, 2023. During the 39 weeks ended September 26, 2024, the Company recognized revenue of $17,208 that was included in deferred revenues as of December 28, 2023. During the 39 weeks ended September 28, 2023, the Company recognized revenue of $14,545 that was included in deferred revenues as of December 29, 2022. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $2,031 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $14,181 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,074 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.
The majority of the Company’s revenue is recognized in less than one year from the original contract.
New Accounting Pronouncements - In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280: Improvements to Reportable Segment Disclosures (ASU No. 2023-07), which requires disclosure of incremental segment information on an annual and interim basis. ASU No 2023-07 will be effective for the Company’s fiscal year ending December 26, 2024, and the Company’s interim periods beginning in fiscal 2025. The Company is evaluating the effect that the guidance will have on its consolidated financial statement disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740: Improvements to Income Tax Disclosures (ASU No. 2023-09), which requires improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid information. ASU No. 2023-09 will be effective for the Company in fiscal 2025 and must be applied prospectively with retrospective application permitted. The Company is evaluating the impact that ASU No. 2023-09 will have on its consolidated financial statement disclosures.
v3.24.3
Long-Term Debt
 9 Months Ended
Sep. 26, 2024
Debt Disclosure [Abstract]  
Long-Term Debt Long-Term Debt
Long-term debt is summarized as follows:
September 26, 2024December 28, 2023
Senior notes$160,000 $70,000 
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%
192 528 
Convertible senior notes13,649 100,050 
Payroll Protection Program loans544 1,233 
Revolving credit agreement— — 
Debt issuance costs(1,292)(1,960)
Total debt, net of debt issuance costs173,093 169,851 
Less current maturities, net of issuance costs10,460 10,303 
Long-term debt$162,633 $159,548 
Credit Agreement
As of September 26, 2024, the Company has a Credit Agreement that provides for a revolving credit facility that matures on October 16, 2028 with an initial maximum aggregate amount of availability of $225,000. At September 26, 2024, there were no borrowings outstanding on the revolving credit facility, which when borrowed, bear interest at the secured overnight financing rate (SOFR) plus a margin (as discussed further below), effectively 6.60% at September 26, 2024. Availability under the $225,000 revolving credit facility was $220,185 as of September 26, 2024 after taking into consideration outstanding letters of credit that reduce revolver availability.
Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) the term SOFR, plus a credit spread adjustment of 0.10%, subject to a 0% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date, or (ii) the alternate base rate (“ABR”) (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month SOFR plus a credit spread adjustment of 0.10%), subject to a 1% floor, plus a specified margin based upon the Company’s net leverage ratio as of the most recent determination date. The revolving credit facility also requires an annual facility fee equal to 0.175% to 0.275% of the total revolving commitments depending on the Company’s consolidated net leverage ratio.
The Credit Agreement includes, among other restrictions and covenants applicable to the Company, a requirement that the Company’s consolidated net leverage ratio not exceed 3.50:1.00, provided that, with some limitations, such ratio may be increased to 4.00:1:00 for the full fiscal quarter in which a material acquisition (in which aggregate consideration equals or
exceeds $30,000) is consummated and the three fiscal quarters immediately thereafter, and a requirement that the Company’s interest coverage ratio at the end of any fiscal quarter not be less than 3.00:1.00.
In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement.
The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.
Note Purchase Agreements
At September 26, 2024, the Company’s $160,000 of senior notes consisted of three Note Purchase Agreements maturing in 2025 through 2034, which require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 7.02%. The weighted average fixed rate of the $160,000 senior notes was 5.94% as of September 26, 2024.
During the 13 weeks ended September 26, 2024, on July 9, 2024, the Company entered into a Master Note Purchase Agreement with several purchasers party to the agreement, pursuant to which the Company issued and sold $100,000 aggregate principal amount of senior notes in two tranches: (i) $60,000 in aggregate principal amount of the Company’s 6.89% Series 2024 Senior Notes, Tranche A due July 9, 2031 (the “Tranche A Notes”) and (ii) $40,000 in aggregate principal amount of the Company’s 7.02% Series 2024 Senior Notes, Tranche B due July 9, 2034 (the “Tranche B Notes” and, collectively with the Tranche A Notes, the “2024 Senior Notes”). The net proceeds were used to refinance the Convertible Notes Repurchases of $99,901 aggregate principal amount of Convertible Notes (see below) and for general corporate purposes.
Interest on the 2024 Senior Notes is payable semi-annually in arrears on the 9th day of January and July each year, commencing on January 9, 2025, and on the applicable maturity date. The Tranche A Notes require annual principal amortization payments beginning in fiscal 2027 with a final maturity in fiscal 2031. The Tranche B Notes require annual principal amortization payments beginning in fiscal 2028 with a final maturity in fiscal 2034. The Master Note Purchase Agreement contains various restrictions and covenants applicable to the Company and certain of its subsidiaries that are consistent with the restrictions, covenants and collateral provisions in the Company’s existing Credit Agreement and Note Purchase Agreements.
Convertible Senior Notes
On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.
The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day
period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.
Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate was 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. The conversion rate is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At September 26, 2024, the applicable conversion rate is 94.3588 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an applicable conversion price of approximately $10.60 per share of Common Stock). The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes.
Since the Company’s fiscal 2021 second quarter through the Company’s fiscal 2024 second quarter, the Company’s Convertible Notes were eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. During the Company’s fiscal 2024 third quarter the Convertible Notes were not eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was not greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. The Convertible Notes are eligible for conversion at the option of the holders during the Company’s fiscal 2024 fourth quarter.
In connection with the pricing of the Convertible Notes on September 17, 2020, and in connection with the exercise by the Initial Purchasers (as defined in the Convertible Notes purchase agreement) of their option to purchase additional Convertible Notes on September 18, 2020, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain of the Initial Purchasers and/or their respective affiliates and/or other financial institutions (the “Capped Call Counterparties”). The Capped Call Transactions are expected generally to reduce potential dilution of the Company’s common stock upon any conversion of the Convertible Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of such converted Convertible Notes, as the case may be, in the event that the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, is greater than the strike price of the Capped Call Transactions, which initially corresponds to the conversion price of the Convertible Notes and is subject to anti-dilution adjustments substantially similar to those applicable to the conversion rate of the Convertible Notes. If, however, the market price per share of the Company’s common stock, as measured under the terms of the Capped Call Transactions, exceeds the cap price of the Capped Call Transactions, there would nevertheless be dilution to the extent that such market price exceeds the cap price of the Capped Call Transactions. The cap price of the Capped Call Transactions was initially $17.98 per share (in no event shall the cap price be less than the strike price of $11.0128), which represents a premium of 100% over the last reported sale price of the Common Stock of $8.99 per share on The New York Stock Exchange on September 17, 2020. Under the terms of the Capped Call Transactions, the cap price is subject to adjustment for certain events, including distributions and dividends paid to holders of Common Stock. At September 26, 2024, the adjusted cap price is approximately $17.30 per share. The Capped Call Transactions are separate transactions entered into by the Company with the Capped Call Counterparties, are not part of the terms of the Convertible Notes and will not change the rights of holders of the Convertible Notes under the Convertible Notes and the Indenture.
Convertible Senior Notes Repurchases
During the 39 weeks ended September 26, 2024, the Company entered into separate, privately negotiated purchase agreements (the “Purchase Agreements”) with certain holders of its Convertible Notes. Under the terms of the Purchase
Agreements, the holders agreed to exchange $99,901 in aggregate principal amount of Convertible Notes for cash consideration of $121,511 (or $103,314 net of the cash received by the Company in connection with the unwind of a portion of the Capped Call Transactions as discussed below) effected over three separate repurchase tranches (the “Convertible Notes Repurchases”). On May 8, 2024, the Company entered into the first repurchase transaction to retire $40,000 of aggregate principal amount of Convertible Notes for $45,879 in cash consideration plus accrued interest, with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, the Company entered into the second repurchase transaction to retire $46,401 of aggregate principal amount of Convertible Notes for $55,208 in cash consideration plus accrued interest, with settlement occurring during the fiscal third quarter on July 16, 2024. On September 19, 2024, the Company entered into the third repurchase transaction to retire $13,500 of aggregate principal amount of Convertible Notes for $20,424 in cash consideration plus accrued interest, with settlement occurring during the fiscal fourth quarter on October 11, 2024. Following settlement of the Convertible Note Repurchases on October 11, 2024, the aggregate principal amount of Convertible Notes outstanding was $149. During the 13 and 39 weeks ended September 26, 2024, the Company incurred debt conversion expense of $1,410 and $15,318, respectively, in connection with the Convertible Notes Repurchases.
In connection with the Convertible Notes Repurchases, the Company entered into unwind agreements with the Capped Call Counterparties to terminate a portion of the Capped Call Transactions equal to the notional amounts of the Convertible Notes Repurchases, and for the Company to receive aggregate cash of $18,197 effected over three separate unwind tranches. On May 8, 2024, the Company entered into the first tranche of unwind agreements and received $5,770 in cash consideration with settlement occurring during the fiscal second quarter on June 14, 2024. On June 17, 2024, the Company entered into the second tranche of unwind agreements and received $7,460 in cash consideration at settlement occurring during the fiscal third quarter on July 16, 2024. On September 19, 2024, the Company entered into the third tranche of unwind agreements and received $4,967 in cash consideration at settlement occurring during the fiscal fourth quarter on October 11, 2024.
v3.24.3
Leases
 9 Months Ended
Sep. 26, 2024
Leases [Abstract]  
Leases Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to Accounting Standards Codification No. 842, Leases. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
Total lease cost consists of the following:
13 Weeks Ended39 Weeks Ended
Lease CostClassificationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Finance lease costs: 
Amortization of finance lease assetsDepreciation and amortization$555 $695 $1,724 $2,074 
Interest on lease liabilitiesInterest expense173 187 508 577 
$728 $882 $2,232 $2,651 
Operating lease costs:
Operating lease costsRent expense$5,891 $6,027 $18,009 $18,104 
Variable lease costRent expense646 526 1,248 1,469 
Short-term lease costRent expense94 39 217 106 
$6,631 $6,592 $19,474 $19,679 
Additional information related to leases is as follows:
13 Weeks Ended39 Weeks Ended
Other InformationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases$628 $703 $1,842 $1,904 
Operating cash flows from finance leases173 187 508 577 
Operating cash flows from operating leases6,067 6,308 18,876 19,167 
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities73 181 188 317 
Operating lease liabilities983 261 3,095 261 
September 26, 2024December 28, 2023
Finance leases:
Property and equipment – gross$29,219 $30,106 
Accumulated depreciation and amortization(18,730)(17,956)
Property and equipment - net$10,489 $12,150 
Remaining lease terms and discount rates are as follows:
Lease Term and Discount RateSeptember 26, 2024December 28, 2023
Weighted-average remaining lease terms:
Finance leases6 years7 years
Operating leases11 years12 years
Weighted-average discount rates:
Finance leases4.68 %4.62 %
Operating leases4.70 %4.52 %
Deferred rent payments of approximately $590 for the Company’s operating leases have been included in the total operating lease obligations as of September 26, 2024, of which approximately $141 is included in long-term operating lease obligations.
Leases Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to Accounting Standards Codification No. 842, Leases. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
Total lease cost consists of the following:
13 Weeks Ended39 Weeks Ended
Lease CostClassificationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Finance lease costs: 
Amortization of finance lease assetsDepreciation and amortization$555 $695 $1,724 $2,074 
Interest on lease liabilitiesInterest expense173 187 508 577 
$728 $882 $2,232 $2,651 
Operating lease costs:
Operating lease costsRent expense$5,891 $6,027 $18,009 $18,104 
Variable lease costRent expense646 526 1,248 1,469 
Short-term lease costRent expense94 39 217 106 
$6,631 $6,592 $19,474 $19,679 
Additional information related to leases is as follows:
13 Weeks Ended39 Weeks Ended
Other InformationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases$628 $703 $1,842 $1,904 
Operating cash flows from finance leases173 187 508 577 
Operating cash flows from operating leases6,067 6,308 18,876 19,167 
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities73 181 188 317 
Operating lease liabilities983 261 3,095 261 
September 26, 2024December 28, 2023
Finance leases:
Property and equipment – gross$29,219 $30,106 
Accumulated depreciation and amortization(18,730)(17,956)
Property and equipment - net$10,489 $12,150 
Remaining lease terms and discount rates are as follows:
Lease Term and Discount RateSeptember 26, 2024December 28, 2023
Weighted-average remaining lease terms:
Finance leases6 years7 years
Operating leases11 years12 years
Weighted-average discount rates:
Finance leases4.68 %4.62 %
Operating leases4.70 %4.52 %
Deferred rent payments of approximately $590 for the Company’s operating leases have been included in the total operating lease obligations as of September 26, 2024, of which approximately $141 is included in long-term operating lease obligations.
v3.24.3
Share Based Compensation
 9 Months Ended
Sep. 26, 2024
Share-Based Payment Arrangement [Abstract]  
Share Based Compensation Share Based Compensation
During the 39 weeks ended September 26, 2024, the Company granted restricted stock, restricted stock units (RSUs) and performance stock units (PSUs) to certain executives and associates.

Restricted Stock and Restricted Stock Units
During the 39 weeks ended September 26, 2024, the Company granted (i) an annual award of restricted stock and RSUs with a vesting period of 50% after two years and 100% after three years, and (ii) a special long-term incentive and retention award of restricted stock to certain executives with a vesting period of 100% after four years, or upon retirement after three years. Restricted stock awards are issued and outstanding common stock at the time of the grant and become unrestricted upon the vesting date. RSU awards are payable in common stock upon vesting. The Company expenses the cost of restricted stock and RSU awards over the vesting period based on the fair value of the award at the date of grant.

Performance Stock Units
During the 39 weeks ended September 26, 2024, the Company granted PSUs with vesting subject to the Company’s achievement of performance goals expressed in terms of (i) earnings before interest, taxes, depreciation and amortization, or EBITDA, growth rate ranking relative to the Russell 2000 Index with respect to 25% of the total number of performance stock unit awards, and (ii) the Company’s average return on invested capital, or ROIC, ranking relative to the Russell 2000 Index with respect to 75% of the total number of performance stock unit awards. For grants awarded in fiscal 2024, the PSU performance goals relate to the three-year performance period from fiscal 2024-2026. PSUs are payable at the end of their respective performance period in common stock, and the number of PSUs awarded can range from zero to 150% depending on the Company’s achievement of the relative performance metrics. The Company expenses the cost of PSUs based on the fair value of the awards at the date of grant and the estimated achievement of the performance metric, ratable over the performance period of three fiscal years.
A summary of the Company’s stock option, restricted stock and RSU and PSU activity and related information follows, with PSUs reflected at the target achievement percentage until the completion of the performance period (shares in thousands):
Stock OptionsRestricted Stock & RSUsPSUs
OptionsWeighted-Average Exercise PriceShares / UnitsWeighted-Average Fair ValueUnitsWeighted-Average Fair Value
December 28, 20233,173 $22.69 238 $17.41 — $— 
Granted— — 503 14.83 143 14.84 
Exercised (1)
— — — — — — 
Vested (2)
— — (47)21.35 — — 
Forfeited(156)18.92 (4)14.84 (4)14.84 
September 26, 20243,017 $22.88 690 $15.28 139 $14.84 
(1)Exercise activity only applicable to stock options.
(2)Vesting activity not applicable to stock options.
Share-based compensation expense was $2,225 and $7,157, respectively, during the 13 and 39 weeks ended September 26, 2024, and $1,313 and $5,000, respectively, during the 13 and 39 weeks ended September 28, 2023. As of September 26, 2024, total unrecognized share-based compensation expense related to stock options was $1,909, which will be amortized to expense over the weighted-average remaining life of 1.9 years. As of September 26, 2024, total unrecognized share-based compensation expense related to non-vested restricted stock, RSUs and PSUs was $6,645, which will be amortized over the weighted-average remaining service period of 2.9 years.
At September 26, 2024, there were 117,441 shares available for grants of additional stock options, restricted stock, RSUs, PSUs and other types of equity awards under the current plan.
v3.24.3
Income Taxes
 9 Months Ended
Sep. 26, 2024
Income Tax Disclosure [Abstract]  
Income Taxes Income TaxesThe Company’s effective income tax rate for the 13 and 39 weeks ended September 26, 2024 was 18.9% and (74.9)%, respectively, and 32.4% and 30.5% for the 13 and 39 weeks ended September 28, 2023, respectively. The fiscal 2024 first three quarters effective income tax rate was negatively impacted by a nondeductible debt conversion expense resulting from the Convertible Notes Repurchases and a $1,217 reduction in deferred tax assets resulting from the related termination of the Capped Call Transactions and excess compensation subject to deduction limitations.
v3.24.3
Joint Venture Transactions
 9 Months Ended
Sep. 26, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Joint Venture Transactions Joint Venture Transactions
In March 2024, the Company formed a joint venture with Hempel Real Estate (“Hempel”) and Robinson Park (“RP”) to acquire the Loews Minneapolis Hotel, a 251 guest room and suite full-service lifestyle hotel located in downtown Minneapolis, Minnesota. The acquired hotel was rebranded as The Lofton Hotel (“Lofton”) under the Tapestry Collection by Hilton flag. The Company invested $5,620 for a 33.3% equity interest in the Lofton joint venture and entered into a management agreement for the hotel. Subsequent to its initial investment in the joint venture, the Company sold an 8.6% interest to a minority investor for $1,500, reducing its equity interest in the Lofton joint venture to 24.7%. The Company accounts for its investment in the Lofton joint venture on the equity method.
A wholly-owned subsidiary of the Lofton joint venture entity, as the borrower, financed the acquisition of and future improvements to the hotel with a mortgage loan. In connection with this mortgage loan, the Company provided an environmental indemnity and a several payment guaranty that provides that the lender can recover losses from the Company, a principal in Hempel, and a principal in RP for certain events of default of the borrower up to $6,200 for the Company. Under the terms of a cross-indemnity agreement among the guarantors, the other two guarantors have fully indemnified the Company under the guarantees for any losses in excess of its proportionate liability under the several payment guaranty and environmental indemnity.
v3.24.3
Business Segment Information
 9 Months Ended
Sep. 26, 2024
Segment Reporting [Abstract]  
Business Segment Information Business Segment Information
The Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.
Following is a summary of business segment information for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023:
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$143,843 $88,738 $87 $232,668 
Operating income (loss)21,761 17,041 (6,020)32,782 
Depreciation and amortization11,347 5,789 138 17,274 
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$126,585 $82,098 $83 $208,766 
Operating income (loss)11,377 14,377 (4,821)20,933 
Depreciation and amortization14,258 4,817 83 19,158 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$326,565 $220,432 $250 $547,247 
Operating income (loss)18,803 17,996 (18,445)18,354 
Depreciation and amortization33,900 15,701 387 49,988 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$359,811 $207,975 $263 $568,049 
Operating income (loss)32,707 15,450 (15,402)32,755 
Depreciation and amortization37,063 13,706 259 51,028 
v3.24.3
Pay vs Performance Disclosure - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Pay vs Performance Disclosure        
Net Income (Loss) $ 23,314 $ 12,234 $ (8,773) $ 16,234
v3.24.3
Insider Trading Arrangements
 3 Months Ended
Sep. 26, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.24.3
General (Policies)
 9 Months Ended
Sep. 26, 2024
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation - The unaudited consolidated financial statements for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at September 26, 2024, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 28, 2023.
Depreciation and Amortization
Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $17,277 and $49,992 for the 13 and 39 weeks ended September 26, 2024, respectively, and $19,150 and $51,004 for the 13 and 39 weeks ended September 28, 2023, respectively.
Assets Held for Sale Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset.
Long-Lived Assets
Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value.
During the 39 weeks ended September 26, 2024, the Company determined that indicators of impairment were present at one asset group for a leased theatre location that the Company made the decision to close during the second quarter of fiscal 2024. As such, the Company evaluated the fair value of these assets, consisting primarily of land improvements, leasehold improvements, building, furniture, fixtures and equipment, and operating lease right-of-use assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset), was less than their carrying values and recorded a $472 impairment loss, reducing certain property and equipment and certain operating lease net obligations. The remaining net book value of the impaired assets as of the date of the asset write-down (June 27, 2024) was $0.
During the 13 weeks ended September 28, 2023, the Company determined that indicators of impairment were present at one theatre asset group. As such, the Company evaluated the fair value of these assets, consisting primarily of land, building and furniture, fixtures and equipment, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $684 impairment loss, reducing certain property and equipment assets. The remaining net book value of the impaired assets as of the date of the asset write-down (September 28, 2023) was $3,040.
Goodwill
Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 39 weeks ended September 26, 2024 or September 28, 2023.
Earnings (Loss) Per Share
Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options, restricted stock units, performance stock units and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.
Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.
The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Net earnings (loss) per share - basic:
Common Stock$0.74 $0.39 $(0.28)$0.52 
Class B Common Stock$0.69 $0.36 $(0.26)$0.48 
Net earnings (loss) per share - diluted:
Common Stock$0.73 $0.32 $(0.28)$0.46 
Class B Common Stock$0.69 $0.31 $(0.26)$0.46 
Numerator:
Net earnings (loss) $23,314 $12,234 $(8,773)$16,234 
Denominator (in thousands):
Denominator for basic EPS31,953 31,691 32,002 31,645 
Effect of dilutive employee stock options17 41 — 48 
Effect of restricted stock units47 — — — 
Effect of convertible senior notes14 9,242 — 9,242 
Diluted weighted-average shares outstanding32,031 40,974 32,002 40,935 
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):
Employee stock options2,800 2,965 2,809 2,965 
Restricted stock units— — 49 — 
Performance stock units139 — 141 — 
Convertible senior notes— — 14 — 
Total2,939 2,965 3,013 2,965 
For the periods when the Company reports a net loss, common stock equivalents, restricted stock units, performance stock units, and shares related to the convertible senior notes are excluded from the computation of diluted loss per share as their inclusion would have an anti-dilutive effect. Performance stock units are considered anti-dilutive if the performance targets upon which the issuance of the shares are contingent have not been achieved and the respective performance period has not been completed as of the end of the current period. Shares related to the convertible senior notes are excluded from the computation of diluted earnings per share in periods when the effect would have been anti-dilutive using the if-converted method.
Fair Value Measurements
Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.
The Company’s assets and liabilities measured at fair value are classified in one of the following categories:
Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At September 26, 2024 and December 28, 2023, the Company’s $7,332 and $5,364 respectively, of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At September 26, 2024 and December 28, 2023, the Company’s $15,014 and $37,018, respectively, of investments in money market funds were valued using Level 1 pricing inputs and were included in cash and cash equivalents.
Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities were measured using Level 2 pricing inputs.
Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At each of September 26, 2024 and December 28, 2023, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets that are measured on a non-recurring basis are discussed above under Long-Lived Assets.
The carrying value of the Company’s financial instruments (including cash and cash equivalents, restricted cash, accounts receivable and accounts payable) approximates fair value. The fair value of the Company’s $160,000 of senior notes, valued using Level 2 pricing inputs, is approximately $160,917 at September 26, 2024, determined based upon discounted cash flows using current market interest rates for financial instruments with a similar average remaining life. The fair value of the Company's $13,649 of convertible senior notes, valued using Level 2 pricing inputs, is approximately $20,183 at September 26, 2024, determined based on market rates and the closing trading price of the convertible senior notes as of September 26, 2024. The carrying amounts of the Company’s remaining long-term debt approximate their fair values, determined using current rates for similar instruments, or Level 2 pricing inputs.
Defined Benefit Plan
Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Service cost$62 $122 $186 $366 
Interest cost445 453 1,334 1,358 
Net amortization of prior service cost and actuarial loss(16)(16)(48)(48)
Net periodic pension cost$491 $559 $1,472 $1,676 
Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.
Revenue Recognition
Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 26, 2024 is as follows:
13 Weeks Ended September 26, 2024
TheatresHotels/Resorts CorporateTotal
Theatre admissions$68,980 $— $— $68,980 
Rooms— 40,019 — 40,019 
Theatre concessions62,118 — — 62,118 
Food and beverage— 22,283 — 22,283 
Other revenues(1)
12,090 16,699 87 28,876 
  Revenue before cost reimbursements143,188 79,001 87 222,276 
Cost reimbursements655 9,737 — 10,392 
Total revenues$143,843 $88,738 $87 $232,668 
39 Weeks Ended September 26, 2024
TheatresHotels/ResortsCorporateTotal
Theatre admissions$158,156 $— $— $158,156 
Rooms— 88,728 — 88,728 
Theatre concessions141,230 — — 141,230 
Food and beverage— 57,718 — 57,718 
Other revenues(1)
26,524 44,338 250 71,112 
  Revenue before cost reimbursements325,910 190,784 250 516,944 
Cost reimbursements655 29,648 — 30,303 
Total revenues$326,565 $220,432 $250 $547,247 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 28, 2023 is as follows:
13 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$63,652 $— $— $63,652 
Rooms— 36,456 — 36,456 
Theatre concessions54,551 — — 54,551 
Food and beverage— 20,214 — 20,214 
Other revenues(1)
8,382 15,443 83 23,908 
  Revenue before cost reimbursements126,585 72,113 83 198,781 
Cost reimbursements— 9,985 — 9,985 
Total revenues$126,585 $82,098 $83 $208,766 
39 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$180,274 $— $— $180,274 
Rooms— 82,959 — 82,959 
Theatre concessions156,633 — — 156,633 
Food and beverage— 53,980 — 53,980 
Other revenues(1)
22,904 41,857 263 65,024 
  Revenue before cost reimbursements359,811 178,796 263 538,870 
Cost reimbursements— 29,179 — 29,179 
Total revenues$359,811 $207,975 $263 $568,049 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The Company had deferred revenue from contracts with customers of $34,463 and $38,034 as of September 26, 2024 and December 28, 2023, respectively. The Company had no contract assets as of September 26, 2024 and December 28, 2023. During the 39 weeks ended September 26, 2024, the Company recognized revenue of $17,208 that was included in deferred revenues as of December 28, 2023. During the 39 weeks ended September 28, 2023, the Company recognized revenue of $14,545 that was included in deferred revenues as of December 29, 2022. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $2,031 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Theatres non-redeemed gift cards was $14,181 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the tickets and gift cards are redeemed, which is expected to occur within the next two years.
As of September 26, 2024, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $4,074 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.
The majority of the Company’s revenue is recognized in less than one year from the original contract.
New Accounting Pronouncements
New Accounting Pronouncements - In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, Segment Reporting (Topic 280: Improvements to Reportable Segment Disclosures (ASU No. 2023-07), which requires disclosure of incremental segment information on an annual and interim basis. ASU No 2023-07 will be effective for the Company’s fiscal year ending December 26, 2024, and the Company’s interim periods beginning in fiscal 2025. The Company is evaluating the effect that the guidance will have on its consolidated financial statement disclosures.
In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740: Improvements to Income Tax Disclosures (ASU No. 2023-09), which requires improvements to income tax disclosures primarily related to rate reconciliation and income taxes paid information. ASU No. 2023-09 will be effective for the Company in fiscal 2025 and must be applied prospectively with retrospective application permitted. The Company is evaluating the impact that ASU No. 2023-09 will have on its consolidated financial statement disclosures.
Leases
The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to Accounting Standards Codification No. 842, Leases. The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.
The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.
v3.24.3
General (Tables)
 9 Months Ended
Sep. 26, 2024
Accounting Policies [Abstract]  
Schedule of Earnings (Loss) Per Share
The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share, provides a reconciliation of the number of weighted-average basic and diluted shares outstanding, when applicable, and provides the weighted-average number of anti-dilutive shares excluded from the computation of diluted weighted-average shares outstanding:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Net earnings (loss) per share - basic:
Common Stock$0.74 $0.39 $(0.28)$0.52 
Class B Common Stock$0.69 $0.36 $(0.26)$0.48 
Net earnings (loss) per share - diluted:
Common Stock$0.73 $0.32 $(0.28)$0.46 
Class B Common Stock$0.69 $0.31 $(0.26)$0.46 
Numerator:
Net earnings (loss) $23,314 $12,234 $(8,773)$16,234 
Denominator (in thousands):
Denominator for basic EPS31,953 31,691 32,002 31,645 
Effect of dilutive employee stock options17 41 — 48 
Effect of restricted stock units47 — — — 
Effect of convertible senior notes14 9,242 — 9,242 
Diluted weighted-average shares outstanding32,031 40,974 32,002 40,935 
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):
Employee stock options2,800 2,965 2,809 2,965 
Restricted stock units— — 49 — 
Performance stock units139 — 141 — 
Convertible senior notes— — 14 — 
Total2,939 2,965 3,013 2,965 
Schedule of Stockholders Equity Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 39 weeks ended September 26, 2024 and September 28, 2023 was as follows:
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Total Shareholders’
Equity
BALANCES AT DECEMBER 28, 2023$24,692 $7,078 $160,642 $281,599 $(1,336)$(1,503)$471,172 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (449)— — (449)
$0.07 per share Common Stock
— — — (1,760)— — (1,760)
Purchase of treasury stock— — — — — (301)(301)
Reissuance of treasury stock— — (3)— — 23 20 
Issuance of non-vested stock452 — (515)— — 63 — 
Shared-based compensation— — 2,514 — — — 2,514 
Conversions of Class B Common Stock93 (93)— — — — — 
Comprehensive loss— — — (11,866)(12)— (11,878)
BALANCES AT MARCH 28, 202425,237 6,985 162,638 267,524 (1,348)(1,718)459,318 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.07 per share Common Stock
— — — (1,763)— — (1,763)
Reissuance of treasury stock— — (7)— — 23 16 
Issuance of non-vested stock— — (326)— — 326 — 
Shared-based compensation— — 2,418 — — — 2,418 
Convertible senior note repurchase— — (2,788)— — — (2,788)
Capped call unwind— — 12,904 — — — 12,904 
Comprehensive loss— — — (20,221)(11)— (20,232)
BALANCES AT JUNE 27, 202425,237 6,985 174,839 245,093 (1,359)(1,369)449,426 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (447)— — (447)
$0.070 per share Common Stock
— — — (1,749)— — (1,749)
Purchase of treasury stock— — — — — (9,667)(9,667)
Reissuance of treasury stock— — 6 — — 16 22 
Issuance of non-vested stock— — (52)— — 52 — 
Shared-based compensation— — 2,225 — — — 2,225 
Convertible senior note repurchase— — (5,472)— — — (5,472)
Capped call unwind— — 4,652 — — — 4,652 
Comprehensive income — — — 23,314 (12)— 23,302 
BALANCES AT SEPTEMBER 26, 2024$25,237 $6,985 $176,198 $266,211 $(1,371)$(10,968)$462,292 
Common
Stock		Class B
Common
Stock		Capital
in Excess
of Par		Retained
Earnings		Accumulated
Other
Comprehensive
Loss		Treasury
Stock		Shareholders’
Equity
Attributable
to The
Marcus
Corporation		Non-
controlling
Interest		Total
Equity
BALANCES AT DECEMBER 29, 2022$24,498 $7,111 $153,794 $274,254 $(1,694)$(1,866)$456,097 $824 $456,921 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,229)— — (1,229)— (1,229)
Exercise of stock options— — (1)— — 3 2 — 2 
Purchase of treasury stock— — — — — (313)(313)— (313)
Savings and profit-sharing contribution79 — 1,180 — — — 1,259 — 1,259 
Reissuance of treasury stock— — (3)— — 24 21 — 21 
Issuance of non-vested stock82 — (143)— — 61 — — — 
Shared-based compensation— — 2,172 — — — 2,172 — 2,172 
Other— — 1 (1)— — — — — 
Conversions of Class B Common Stock33 (33)— — — — — — — 
Distribution to noncontrolling interest— — — — — — — (550)(550)
Comprehensive loss— — — (9,466)(91)— (9,557)— (9,557)
BALANCES AT MARCH 30, 202324,692 7,078 157,000 263,239 (1,785)(2,091)448,133 274 448,407 
Cash dividends:
$0.045 per share Class B Common Stock
— — — (319)— — (319)— (319)
$0.05 per share Common Stock
— — — (1,230)— — (1,230)— (1,230)
Exercise of stock options— — (25)— — 121 96 — 96 
Purchase of treasury stock— — — — — (226)(226)— (226)
Reissuance of treasury stock— — (204)— — 223 19 — 19 
Issuance of non-vested stock— — (55)— — 55 — — — 
Shared-based compensation— — 1,515 — — — 1,515 — 1,515 
Other— — — 1 — (1)— — — 
Distribution to noncontrolling interest— — — — — — — (274)(274)
Comprehensive income (loss)— — — 13,466 (12)— 13,454 — 13,454 
BALANCES AT JUNE 29, 202324,692 7,078 158,231 275,157 (1,797)(1,919)461,442 — 461,442 
Cash dividends:
$0.064 per share Class B Common Stock
— — — (453)— — (453)— (453)
$0.07 per share Common Stock
— — — (1,723)— — (1,723)— (1,723)
Exercise of stock options— — (184)— — 1,171 987 — 987 
Purchase of treasury stock— — — — — (914)(914)— (914)
Reissuance of treasury stock— — (3)— — 27 24 — 24 
Issuance of non-vested stock— — (53)— — 53 — — — 
Shared-based compensation— — 1,313 — — — 1,313 — 1,313 
Comprehensive income — — — 12,234 (12)— 12,222 — 12,222 
BALANCES AT SEPTEMBER 28, 2023$24,692 $7,078 $159,304 $285,215 $(1,809)$(1,582)$472,898 $— $472,898 
Schedule of Accumulated Other Comprehensive Income (Loss) Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:
September 26,
2024		December 28,
2023
Net unrecognized actuarial loss for pension obligation$(1,371)$(1,336)
$(1,371)$(1,336)
Schedule of Defined Benefit Plan The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:
13 Weeks Ended39 Weeks Ended
September 26, 2024September 28, 2023September 26, 2024September 28, 2023
Service cost$62 $122 $186 $366 
Interest cost445 453 1,334 1,358 
Net amortization of prior service cost and actuarial loss(16)(16)(48)(48)
Net periodic pension cost$491 $559 $1,472 $1,676 
Schedule of Disaggregation of Revenue The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 26, 2024 is as follows:
13 Weeks Ended September 26, 2024
TheatresHotels/Resorts CorporateTotal
Theatre admissions$68,980 $— $— $68,980 
Rooms— 40,019 — 40,019 
Theatre concessions62,118 — — 62,118 
Food and beverage— 22,283 — 22,283 
Other revenues(1)
12,090 16,699 87 28,876 
  Revenue before cost reimbursements143,188 79,001 87 222,276 
Cost reimbursements655 9,737 — 10,392 
Total revenues$143,843 $88,738 $87 $232,668 
39 Weeks Ended September 26, 2024
TheatresHotels/ResortsCorporateTotal
Theatre admissions$158,156 $— $— $158,156 
Rooms— 88,728 — 88,728 
Theatre concessions141,230 — — 141,230 
Food and beverage— 57,718 — 57,718 
Other revenues(1)
26,524 44,338 250 71,112 
  Revenue before cost reimbursements325,910 190,784 250 516,944 
Cost reimbursements655 29,648 — 30,303 
Total revenues$326,565 $220,432 $250 $547,247 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
The disaggregation of revenues by business segment for the 13 and 39 weeks ended September 28, 2023 is as follows:
13 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$63,652 $— $— $63,652 
Rooms— 36,456 — 36,456 
Theatre concessions54,551 — — 54,551 
Food and beverage— 20,214 — 20,214 
Other revenues(1)
8,382 15,443 83 23,908 
  Revenue before cost reimbursements126,585 72,113 83 198,781 
Cost reimbursements— 9,985 — 9,985 
Total revenues$126,585 $82,098 $83 $208,766 
39 Weeks Ended September 28, 2023
TheatresHotels/ResortsCorporateTotal
Theatre admissions$180,274 $— $— $180,274 
Rooms— 82,959 — 82,959 
Theatre concessions156,633 — — 156,633 
Food and beverage— 53,980 — 53,980 
Other revenues(1)
22,904 41,857 263 65,024 
  Revenue before cost reimbursements359,811 178,796 263 538,870 
Cost reimbursements— 29,179 — 29,179 
Total revenues$359,811 $207,975 $263 $568,049 
(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.
v3.24.3
Long-Term Debt (Tables)
 9 Months Ended
Sep. 26, 2024
Debt Disclosure [Abstract]  
Schedule of Long-term debt and short-term borrowings
Long-term debt is summarized as follows:
September 26, 2024December 28, 2023
Senior notes$160,000 $70,000 
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%
192 528 
Convertible senior notes13,649 100,050 
Payroll Protection Program loans544 1,233 
Revolving credit agreement— — 
Debt issuance costs(1,292)(1,960)
Total debt, net of debt issuance costs173,093 169,851 
Less current maturities, net of issuance costs10,460 10,303 
Long-term debt$162,633 $159,548 
v3.24.3
Leases (Tables)
 9 Months Ended
Sep. 26, 2024
Leases [Abstract]  
Schedule of Lease Cost
Total lease cost consists of the following:
13 Weeks Ended39 Weeks Ended
Lease CostClassificationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Finance lease costs: 
Amortization of finance lease assetsDepreciation and amortization$555 $695 $1,724 $2,074 
Interest on lease liabilitiesInterest expense173 187 508 577 
$728 $882 $2,232 $2,651 
Operating lease costs:
Operating lease costsRent expense$5,891 $6,027 $18,009 $18,104 
Variable lease costRent expense646 526 1,248 1,469 
Short-term lease costRent expense94 39 217 106 
$6,631 $6,592 $19,474 $19,679 
Schedule of Other Information Related to Leases
Additional information related to leases is as follows:
13 Weeks Ended39 Weeks Ended
Other InformationSeptember 26, 2024September 28, 2023September 26, 2024September 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases$628 $703 $1,842 $1,904 
Operating cash flows from finance leases173 187 508 577 
Operating cash flows from operating leases6,067 6,308 18,876 19,167 
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities73 181 188 317 
Operating lease liabilities983 261 3,095 261 
September 26, 2024December 28, 2023
Finance leases:
Property and equipment – gross$29,219 $30,106 
Accumulated depreciation and amortization(18,730)(17,956)
Property and equipment - net$10,489 $12,150 
Schedule of Lease Term and Discount Rate
Remaining lease terms and discount rates are as follows:
Lease Term and Discount RateSeptember 26, 2024December 28, 2023
Weighted-average remaining lease terms:
Finance leases6 years7 years
Operating leases11 years12 years
Weighted-average discount rates:
Finance leases4.68 %4.62 %
Operating leases4.70 %4.52 %
v3.24.3
Share Based Compensation (Tables)
 9 Months Ended
Sep. 26, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule Of Share-Based Payment Arrangement, Activity
A summary of the Company’s stock option, restricted stock and RSU and PSU activity and related information follows, with PSUs reflected at the target achievement percentage until the completion of the performance period (shares in thousands):
Stock OptionsRestricted Stock & RSUsPSUs
OptionsWeighted-Average Exercise PriceShares / UnitsWeighted-Average Fair ValueUnitsWeighted-Average Fair Value
December 28, 20233,173 $22.69 238 $17.41 — $— 
Granted— — 503 14.83 143 14.84 
Exercised (1)
— — — — — — 
Vested (2)
— — (47)21.35 — — 
Forfeited(156)18.92 (4)14.84 (4)14.84 
September 26, 20243,017 $22.88 690 $15.28 139 $14.84 
(1)Exercise activity only applicable to stock options.
(2)Vesting activity not applicable to stock options.
v3.24.3
Business Segment Information (Tables)
 9 Months Ended
Sep. 26, 2024
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information, by Segment
Following is a summary of business segment information for the 13 and 39 weeks ended September 26, 2024 and September 28, 2023:
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$143,843 $88,738 $87 $232,668 
Operating income (loss)21,761 17,041 (6,020)32,782 
Depreciation and amortization11,347 5,789 138 17,274 
13 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$126,585 $82,098 $83 $208,766 
Operating income (loss)11,377 14,377 (4,821)20,933 
Depreciation and amortization14,258 4,817 83 19,158 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 26, 2024
Revenues$326,565 $220,432 $250 $547,247 
Operating income (loss)18,803 17,996 (18,445)18,354 
Depreciation and amortization33,900 15,701 387 49,988 
39 Weeks EndedTheatresHotels/
Resorts		Corporate
Items		Total
September 28, 2023
Revenues$359,811 $207,975 $263 $568,049 
Operating income (loss)32,707 15,450 (15,402)32,755 
Depreciation and amortization37,063 13,706 259 51,028 
v3.24.3
General - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Jun. 27, 2024
Sep. 26, 2024
Sep. 28, 2023
Dec. 28, 2023
Summary of Significant Accounting Policies [Line Items]            
Depreciation $ 17,277,000 $ 19,150,000   $ 49,992,000 $ 51,004,000  
Goodwill, impairment loss       $ 0 0  
Percentage of cash dividends       110.00%    
Cash and cash equivalents 28,415,000     $ 28,415,000   $ 55,589,000
Senior notes 160,000,000     160,000,000   70,000,000
Convertible senior notes 13,649,000     13,649,000   100,050,000
Deferred revenue 34,463,000     34,463,000   38,034,000
Contract assets 0     0   0
Deferred revenue, revenue recognized       17,208,000 14,545,000  
Theatres | Operating Segments            
Summary of Significant Accounting Policies [Line Items]            
Remaining performance obligation related to gift cards 14,181,000     14,181,000    
Hotels/ Resorts | Operating Segments            
Summary of Significant Accounting Policies [Line Items]            
Remaining performance obligation related to hotels gift cards 4,074,000     $ 4,074,000    
Expected period for revenue from non-redeemed gift cards       2 years    
Advanced Sale Of Tickets            
Summary of Significant Accounting Policies [Line Items]            
Remaining performance obligation, amount 2,031,000     $ 2,031,000    
Expected period for redeemed revenue from advanced tickets and gift cards sales occurred       2 years    
Level 3            
Summary of Significant Accounting Policies [Line Items]            
Impairment of fixed assets   684,000 $ 472,000      
Impaired assets   $ 3,040,000 $ 0   $ 3,040,000  
Level 3 | Recurring            
Summary of Significant Accounting Policies [Line Items]            
Fair value, asset (liability) 0     $ 0   0
Level 1            
Summary of Significant Accounting Policies [Line Items]            
Trading securities, fair value 7,332,000     7,332,000   5,364,000
Level 1 | Money Market Funds            
Summary of Significant Accounting Policies [Line Items]            
Cash and cash equivalents 15,014,000     15,014,000   37,018,000
Level 2            
Summary of Significant Accounting Policies [Line Items]            
Senior notes 160,917,000     160,917,000    
Level 2 | Convertible Debt            
Summary of Significant Accounting Policies [Line Items]            
Debt instrument, fair value 20,183,000     20,183,000    
Level 2 | Recurring            
Summary of Significant Accounting Policies [Line Items]            
Fair value, asset (liability) $ 0     $ 0   $ 0
v3.24.3
General - Schedule of Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Numerator:        
Net earnings (loss) $ 23,314 $ 12,234 $ (8,773) $ 16,234
Denominator        
Denominator for basic EPS (in shares) 31,953 31,691 32,002 31,645
Effect of dilutive employee stock options (in shares) 17 41 0 48
Effect of restricted stock units (in shares) 47 0 0 0
Effect of convertible senior notes (in shares) 14 9,242 0 9,242
Diluted weighted-average shares outstanding (in shares) 32,031 40,974 32,002 40,935
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):        
Weighted-average number of anti-dilutive shares excluded from denominator (in shares) 2,939 2,965 3,013 2,965
Employee stock options        
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):        
Weighted-average number of anti-dilutive shares excluded from denominator (in shares) 2,800 2,965 2,809 2,965
Restricted stock units        
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):        
Weighted-average number of anti-dilutive shares excluded from denominator (in shares) 0 0 49 0
Performance stock units        
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):        
Weighted-average number of anti-dilutive shares excluded from denominator (in shares) 139 0 141 0
Convertible senior notes        
Weighted-average number of anti-dilutive shares excluded from denominator (in thousands):        
Weighted-average number of anti-dilutive shares excluded from denominator (in shares) 0 0 14 0
Common Stock        
Net earnings (loss) per share - basic:        
Net earnings (loss) per share - basic (in dollars per share) $ 0.74 $ 0.39 $ (0.28) $ 0.52
Net earnings (loss) per share - diluted:        
Net earnings (loss) per share - diluted (in dollars per share) 0.73 0.32 (0.28) 0.46
Class B Common Stock        
Net earnings (loss) per share - basic:        
Net earnings (loss) per share - basic (in dollars per share) 0.69 0.36 (0.26) 0.48
Net earnings (loss) per share - diluted:        
Net earnings (loss) per share - diluted (in dollars per share) $ 0.69 $ 0.31 $ (0.26) $ 0.46
v3.24.3
General - Schedule of Shareholders' Equity (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Jun. 27, 2024
Mar. 28, 2024
Sep. 28, 2023
Jun. 29, 2023
Mar. 30, 2023
Sep. 26, 2024
Sep. 28, 2023
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance       $ 461,442 $ 448,407 $ 456,921   $ 456,921
Cash dividends $ (1,749) $ (1,763) $ (1,760) (1,723) (1,230) (1,229)    
Exercise of stock options       987 96 2    
Purchase of treasury stock (9,667)   (301) (914) (226) (313)    
Savings and profit-sharing contribution           1,259    
Reissuance of treasury stock 22 16 20 24 19 21    
Issuance of non-vested stock 0 0 0 0 0 0    
Shared-based compensation 2,225 2,418 2,514 1,313 1,515 2,172    
Other         0 0    
Conversions of Class B Common Stock     0     0    
Distribution to noncontrolling interest         (274) (550)    
Convertible senior note repurchase (5,472) (2,788)            
Capped call unwind 4,652 12,904            
Comprehensive income (loss) 23,302 (20,232) (11,878) 12,222 13,454 (9,557) $ (8,808) 16,119
Ending balance       472,898 461,442 448,407   472,898
Shareholders’ Equity Attributable to The Marcus Corporation                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 449,426 459,318 471,172 461,442 448,133 456,097 471,172 456,097
Cash dividends       (1,723) (1,230) (1,229)    
Exercise of stock options       987 96 2    
Purchase of treasury stock       (914) (226) (313)    
Savings and profit-sharing contribution           1,259    
Reissuance of treasury stock       24 19 21    
Issuance of non-vested stock       0 0 0    
Shared-based compensation       1,313 1,515 2,172    
Other         0 0    
Conversions of Class B Common Stock           0    
Distribution to noncontrolling interest         0 0    
Comprehensive income (loss)       12,222 13,454 (9,557)    
Ending balance 462,292 449,426 459,318 472,898 461,442 448,133 462,292 472,898
Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 25,237 25,237 24,692 24,692 24,692 24,498 24,692 24,498
Savings and profit-sharing contribution           79    
Issuance of non-vested stock     452     82    
Conversions of Class B Common Stock     93     33    
Ending balance 25,237 25,237 25,237 24,692 24,692 24,692 25,237 24,692
Capital in Excess of Par                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 174,839 162,638 160,642 158,231 157,000 153,794 160,642 153,794
Exercise of stock options       (184) (25) (1)    
Savings and profit-sharing contribution           1,180    
Reissuance of treasury stock 6 (7) (3) (3) (204) (3)    
Issuance of non-vested stock (52) (326) (515) (53) (55) (143)    
Shared-based compensation 2,225 2,418 2,514 1,313 1,515 2,172    
Other           1    
Convertible senior note repurchase (5,472) (2,788)            
Capped call unwind 4,652 12,904            
Ending balance 176,198 174,839 162,638 159,304 158,231 157,000 176,198 159,304
Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 245,093 267,524 281,599 275,157 263,239 274,254 281,599 274,254
Cash dividends (1,749) (1,763) (1,760) (1,723) (1,230) (1,229)    
Other         1 (1)    
Comprehensive income (loss) 23,314 (20,221) (11,866) 12,234 13,466 (9,466)    
Ending balance 266,211 245,093 267,524 285,215 275,157 263,239 266,211 285,215
Accumulated Other Comprehensive Loss                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (1,359) (1,348) (1,336) (1,797) (1,785) (1,694) (1,336) (1,694)
Comprehensive income (loss) (12) (11) (12) (12) (12) (91)    
Ending balance (1,371) (1,359) (1,348) (1,809) (1,797) (1,785) (1,371) (1,809)
Treasury Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance (1,369) (1,718) (1,503) (1,919) (2,091) (1,866) (1,503) (1,866)
Exercise of stock options       1,171 121 3    
Purchase of treasury stock (9,667)   (301) (914) (226) (313)    
Reissuance of treasury stock 16 23 23 27 223 24    
Issuance of non-vested stock 52 326 63 53 55 61    
Other         (1)      
Ending balance $ (10,968) $ (1,369) $ (1,718) (1,582) (1,919) (2,091) (10,968) (1,582)
Non- controlling Interest                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance       0 274 824   824
Distribution to noncontrolling interest         (274) (550)    
Ending balance       $ 0 $ 0 $ 274   0
Common Stock                
Common stock, dividends (in dollars per share) $ 0.070 $ 0.07 $ 0.07 $ 0.07 $ 0.05 $ 0.05    
Class B Common Stock                
Common stock, dividends (in dollars per share) $ 0.064 $ 0.064 $ 0.064 $ 0.064 $ 0.045 $ 0.045    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cash dividends $ (447) $ (447) $ (449) $ (453) $ (319) $ (319)    
Class B Common Stock | Shareholders’ Equity Attributable to The Marcus Corporation                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cash dividends       (453) (319) (319)    
Class B Common Stock | Common Stock                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Beginning balance 6,985 6,985 7,078 7,078 7,078 7,111 7,078 7,111
Conversions of Class B Common Stock     (93)     (33)    
Ending balance 6,985 6,985 6,985 7,078 7,078 7,078 $ 6,985 $ 7,078
Class B Common Stock | Retained Earnings                
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cash dividends $ (447) $ (447) $ (449) $ (453) $ (319) $ (319)    
v3.24.3
General - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
Sep. 26, 2024
Dec. 28, 2023
Accounting Policies [Abstract]    
Net unrecognized actuarial loss for pension obligation $ (1,371) $ (1,336)
Accumulated other comprehensive loss $ (1,371) $ (1,336)
v3.24.3
General - Schedule of Defined Benefit Plan (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Accounting Policies [Abstract]        
Service cost $ 62 $ 122 $ 186 $ 366
Interest cost 445 453 1,334 1,358
Net amortization of prior service cost and actuarial loss (16) (16) (48) (48)
Net periodic pension cost $ 491 $ 559 $ 1,472 $ 1,676
v3.24.3
General - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Summary of Significant Accounting Policies [Line Items]        
Revenue before cost reimbursements $ 222,276 $ 198,781 $ 516,944 $ 538,870
Cost reimbursements 10,392 9,985 30,303 29,179
Total revenues 232,668 208,766 547,247 568,049
Theatre admissions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 68,980 63,652 158,156 180,274
Rooms        
Summary of Significant Accounting Policies [Line Items]        
Revenues 40,019 36,456 88,728 82,959
Theatre concessions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 62,118 54,551 141,230 156,633
Food and beverage        
Summary of Significant Accounting Policies [Line Items]        
Revenues 22,283 20,214 57,718 53,980
Other revenues        
Summary of Significant Accounting Policies [Line Items]        
Revenues 28,876 23,908 71,112 65,024
Operating Segments | Theatres        
Summary of Significant Accounting Policies [Line Items]        
Revenue before cost reimbursements 143,188 126,585 325,910 359,811
Cost reimbursements 655 0 655 0
Total revenues 143,843 126,585 326,565 359,811
Operating Segments | Theatres | Theatre admissions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 68,980 63,652 158,156 180,274
Operating Segments | Theatres | Rooms        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Operating Segments | Theatres | Theatre concessions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 62,118 54,551 141,230 156,633
Operating Segments | Theatres | Food and beverage        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Operating Segments | Theatres | Other revenues        
Summary of Significant Accounting Policies [Line Items]        
Revenues 12,090 8,382 26,524 22,904
Operating Segments | Hotels/ Resorts        
Summary of Significant Accounting Policies [Line Items]        
Revenue before cost reimbursements 79,001 72,113 190,784 178,796
Cost reimbursements 9,737 9,985 29,648 29,179
Total revenues 88,738 82,098 220,432 207,975
Operating Segments | Hotels/ Resorts | Theatre admissions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Operating Segments | Hotels/ Resorts | Rooms        
Summary of Significant Accounting Policies [Line Items]        
Revenues 40,019 36,456 88,728 82,959
Operating Segments | Hotels/ Resorts | Theatre concessions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Operating Segments | Hotels/ Resorts | Food and beverage        
Summary of Significant Accounting Policies [Line Items]        
Revenues 22,283 20,214 57,718 53,980
Operating Segments | Hotels/ Resorts | Other revenues        
Summary of Significant Accounting Policies [Line Items]        
Revenues 16,699 15,443 44,338 41,857
Corporate Items        
Summary of Significant Accounting Policies [Line Items]        
Revenue before cost reimbursements 87 83 250 263
Cost reimbursements 0 0 0 0
Total revenues 87 83 250 263
Corporate Items | Theatre admissions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Corporate Items | Rooms        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Corporate Items | Theatre concessions        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Corporate Items | Food and beverage        
Summary of Significant Accounting Policies [Line Items]        
Revenues 0 0 0 0
Corporate Items | Other revenues        
Summary of Significant Accounting Policies [Line Items]        
Revenues $ 87 $ 83 $ 250 $ 263
v3.24.3
Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($)
$ in Thousands
 9 Months Ended 12 Months Ended
Sep. 26, 2024
Dec. 28, 2023
Debt Disclosure [Abstract]    
Principal and interest payments $ 39 $ 39
Interest rate of unsecured term note (as percent) 5.75% 5.75%
Senior notes $ 160,000 $ 70,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75% 192 528
Convertible senior notes 13,649 100,050
Payroll Protection Program loans 544 1,233
Revolving credit agreement 0 0
Debt issuance costs (1,292) (1,960)
Total debt, net of debt issuance costs 173,093 169,851
Less current maturities, net of issuance costs 10,460 10,303
Long-term debt $ 162,633 $ 159,548
v3.24.3
Long-Term Debt - Narrative (Details)
 3 Months Ended 9 Months Ended 11 Months Ended 39 Months Ended
Sep. 26, 2024
USD ($)
agreement
$ / shares
Jul. 09, 2024
USD ($)
Sep. 17, 2020
USD ($)
$ / shares
Sep. 26, 2024
USD ($)
agreement
$ / shares
Sep. 26, 2024
USD ($)
agreement
$ / shares
Sep. 26, 2024
USD ($)
agreement
$ / shares
Jun. 27, 2024
Sep. 19, 2024
USD ($)
Jun. 17, 2024
USD ($)
May 08, 2024
USD ($)
Dec. 28, 2023
USD ($)
Oct. 16, 2023
USD ($)
Sep. 22, 2020
Debt Instrument [Line Items]                          
Revolving credit agreement $ 0     $ 0 $ 0 $ 0         $ 0    
Senior notes $ 160,000,000     $ 160,000,000 $ 160,000,000 $ 160,000,000         $ 70,000,000    
Trading period       20 days     20 days            
Threshold trading days       30 days     30 days            
Debt instrument, convertible, threshold percentage of stock price trigger       130.00%     130.00%            
Initial conversion premium     100.00%                    
Share price (in dollars per share) | $ / shares     $ 8.99                    
Cap price of capped call transactions (in dollars per share) | $ / shares $ 17.30   17.98 $ 17.30 $ 17.30 $ 17.30              
Strike price of capped call transactions (in dollars per share) | $ / shares     $ 11.0128                    
Note Purchase Agreement                          
Debt Instrument [Line Items]                          
Senior notes $ 160,000,000     $ 160,000,000 $ 160,000,000 $ 160,000,000              
Number of purchase agreements | agreement 3     3 3 3              
Senior Notes                          
Debt Instrument [Line Items]                          
Debt instrument, weighted average interest rate 5.94%     5.94% 5.94% 5.94%              
Face amount   $ 100,000,000                      
Proceeds from issuance of debt   $ 100,000,000                      
Convertible Debt                          
Debt Instrument [Line Items]                          
Debt instrument, interest rate, stated percentage     5.00%                   5.00%
Face amount     $ 100,050,000                    
Trading period         20 days                
Threshold trading days         30 days                
Debt instrument, convertible, threshold percentage of stock price trigger         130.00%                
Measurement period         5 days                
Consecutive trading day period         5 days                
Conversion rate 0.0943588   0.0908038                    
Debt instrument, convertible, conversion price (in dollars per share) | $ / shares $ 10.60   $ 11.01 $ 10.60 $ 10.60 $ 10.60              
Initial conversion premium     22.50%                    
Share price (in dollars per share) | $ / shares     $ 8.99                    
6.89% Series 2024 Senior Notes, Tranche A | Senior Notes                          
Debt Instrument [Line Items]                          
Debt instrument, interest rate, stated percentage   6.89%                      
Face amount   $ 60,000,000                      
Proceeds from issuance of debt   $ 60,000,000                      
7.02% Series 2024 Senior Notes, Tranche B | Senior Notes                          
Debt Instrument [Line Items]                          
Debt instrument, interest rate, stated percentage   7.02%                      
Face amount   $ 40,000,000                      
Proceeds from issuance of debt   $ 40,000,000                      
Convertible Senior Notes Repurchases | Convertible Debt                          
Debt Instrument [Line Items]                          
Debt instrument, repurchased face amount $ 99,901,000     $ 99,901,000 $ 99,901,000 $ 99,901,000   $ 13,500,000 $ 46,401,000 $ 40,000,000      
Minimum | Note Purchase Agreement                          
Debt Instrument [Line Items]                          
Debt instrument, interest rate, stated percentage 4.02%     4.02% 4.02% 4.02%              
Maximum | Note Purchase Agreement                          
Debt Instrument [Line Items]                          
Debt instrument, interest rate, stated percentage 7.02%     7.02% 7.02% 7.02%              
Maximum | Convertible Debt                          
Debt Instrument [Line Items]                          
Debt instrument, convertible, threshold percentage of stock price trigger         98.00%                
Revolving Credit Facility                          
Debt Instrument [Line Items]                          
Maximum borrowing capacity                       $ 225,000,000  
Revolving credit agreement $ 0     $ 0 $ 0 $ 0              
Effective interest rate 6.60%     6.60% 6.60% 6.60%              
Available facility $ 220,185,000     $ 220,185,000 $ 220,185,000 $ 220,185,000              
Debt instrument, net leverage ratio           3.50              
Material acquisition benchmark amount $ 30,000     $ 30,000 $ 30,000 $ 30,000              
Interest coverage ratio           3.00              
Revolving Credit Facility | Minimum                          
Debt Instrument [Line Items]                          
Facility fee (as a percent)           0.175%              
Revolving Credit Facility | Maximum                          
Debt Instrument [Line Items]                          
Facility fee (as a percent)           0.275%              
Revolving Credit Facility | Greater of Federal Funds Rate or Overnight Bank Funding Rate                          
Debt Instrument [Line Items]                          
Specified margin (as a percent)           0.50%              
Revolving Credit Facility | For Full Fiscal Quarter If Material Acquisition Is Consummated                          
Debt Instrument [Line Items]                          
Debt instrument, net leverage ratio           4.00              
Revolving Credit Facility | SOFR                          
Debt Instrument [Line Items]                          
Specified margin (as a percent)           0.10%              
Floor interest rate 0.00%     0.00% 0.00% 0.00%              
Revolving Credit Facility | SOFR | Based Upon Net Leverage Ratio                          
Debt Instrument [Line Items]                          
Specified margin (as a percent)           1.00%              
Floor interest rate 1.00%     1.00% 1.00% 1.00%              
Revolving Credit Facility | One-Month Secured Overnight Financing Rate (SOFR) | Based Upon Net Leverage Ratio                          
Debt Instrument [Line Items]                          
Specified margin (as a percent)           0.10%              
v3.24.3
Long-Term Debt - Convertible Senior Notes Repurchases (Details)
 3 Months Ended 6 Months Ended 9 Months Ended
Oct. 11, 2024
USD ($)
Jul. 16, 2024
USD ($)
Jun. 14, 2024
USD ($)
Sep. 26, 2024
USD ($)
tranche
Sep. 28, 2023
USD ($)
Sep. 26, 2024
USD ($)
tranche
Sep. 26, 2024
USD ($)
tranche
Sep. 28, 2023
USD ($)
Sep. 19, 2024
USD ($)
Jun. 17, 2024
USD ($)
May 08, 2024
USD ($)
Debt Instrument [Line Items]                      
Debt conversion expense       $ 1,410,000 $ 0   $ 15,318,000 $ 0      
Convertible Debt | Convertible Senior Notes Repurchases                      
Debt Instrument [Line Items]                      
Debt instrument, repurchased face amount       99,901,000   $ 99,901,000 99,901,000   $ 13,500,000 $ 46,401,000 $ 40,000,000
Debt instrument, repurchase amount   $ 55,208,000 $ 45,879,000 121,511,000   121,511,000 121,511,000        
Debt instrument, repurchase amount, net of cash received       $ 103,314,000   $ 103,314,000 $ 103,314,000        
Debt instrument, number of repurchase tranches | tranche       3   3 3        
Debt conversion expense       $ 1,410,000     $ 15,318,000        
Proceeds from capped call unwinds   $ 7,460,000 $ 5,770,000     $ 18,197,000          
Debt instrument, number of unwind tranches | tranche       3   3 3        
Convertible Debt | Convertible Senior Notes Repurchases | Subsequent Event                      
Debt Instrument [Line Items]                      
Debt instrument, repurchase amount $ 20,424,000                    
Borrowing outstanding 149,000                    
Proceeds from capped call unwinds $ 4,967,000                    
v3.24.3
Leases - Narrative (Details)
$ in Thousands
Sep. 26, 2024
USD ($)
Deferred rent payments under operating lease $ 590
Long-Term Operating Lease Obligations  
Deferred rent payments under operating lease $ 141
Minimum  
Lease terms (in years) 1 year
Maximum  
Lease terms (in years) 45 years
v3.24.3
Leases - Schedule of Lease Cost (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Finance lease costs:        
Amortization of finance lease assets $ 555 $ 695 $ 1,724 $ 2,074
Interest on lease liabilities 173 187 508 577
Total finance lease costs 728 882 2,232 2,651
Operating lease costs:        
Operating lease costs 5,891 6,027 18,009 18,104
Variable lease cost 646 526 1,248 1,469
Short-term lease cost 94 39 217 106
Total operating lease costs $ 6,631 $ 6,592 $ 19,474 $ 19,679
v3.24.3
Leases - Schedule of Other Information Related to Leases (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Cash paid for amounts included in the measurement of lease liabilities:        
Financing cash flows from finance leases $ 628 $ 703 $ 1,842 $ 1,904
Operating cash flows from finance leases 173 187 508 577
Operating cash flows from operating leases 6,067 6,308 18,876 19,167
Right of use assets obtained in exchange for new lease obligations:        
Finance lease liabilities 73 181 188 317
Operating lease liabilities $ 983 $ 261 $ 3,095 $ 261
v3.24.3
Leases - Schedule of Finance Leases (Details) - USD ($)
$ in Thousands
Sep. 26, 2024
Dec. 28, 2023
Finance leases:    
Property and equipment – gross $ 29,219 $ 30,106
Accumulated depreciation and amortization (18,730) (17,956)
Finance lease right-of-use assets $ 10,489 $ 12,150
v3.24.3
Leases - Schedule of Lease Term and Discount Rate (Details)
Sep. 26, 2024
Dec. 28, 2023
Weighted-average remaining lease terms:    
Finance leases 6 years 7 years
Operating leases 11 years 12 years
Weighted-average discount rates:    
Finance leases 4.68% 4.62%
Operating leases 4.70% 4.52%
v3.24.3
Share Based Compensation - Narrative (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-based compensation $ 2,225 $ 1,313 $ 7,157 $ 5,000
Share based payment arrangement cost not yet recognized $ 6,645   $ 6,645  
Shares available for grants of additional stock options, non-vested stock (in shares) 117,441   117,441  
PSUs        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Performance period     3 years  
Share-based payment arrangement, weighted-average remaining life     2 years 10 months 24 days  
PSUs | Minimum        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Percent of stock awarded based on performance     0.00%  
PSUs | Maximum        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Percent of stock awarded based on performance     150.00%  
PSUs | Earnings Before Interest, Taxes, Depreciation and Amortization Growth Rate        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Vesting percentage of number of performance shares upon achievement     25.00%  
PSUs | Average Return on Invested Capital        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Vesting percentage of number of performance shares upon achievement     75.00%  
Stock Options        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-based compensation expense unrecognized $ 1,909   $ 1,909  
Share-based payment arrangement, weighted-average remaining life     1 year 10 months 24 days  
Restricted stock units        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Share-based payment arrangement, weighted-average remaining life     2 years 10 months 24 days  
After Two Years | Restricted Stock & RSUs        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Award options grants in period exercisable percentage     50.00%  
After Three Years | Restricted Stock & RSUs        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Award options grants in period exercisable percentage     100.00%  
After Four Years | Restricted Stock        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Award options grants in period exercisable percentage     100.00%  
v3.24.3
Share Based Compensation - Schedule Of Stock Option, Restricted Stock ,Restricted Stock Units And PSU Activity (Details) - $ / shares
shares in Thousands
 9 Months Ended
Sep. 26, 2024
Dec. 28, 2023
Stock Options    
Options    
Outstanding at beginning of period (in shares) 3,173  
Granted (in shares) 0  
Exercised (in shares) 0  
Vested (in shares) 0  
Forfeited (in shares) (156)  
Outstanding at ending of period (in shares) 3,017  
Weighted-Average Exercise Price    
Outstanding at beginning of period (in dollars per shares) $ 22.88 $ 22.69
Granted (in dollars per share) 0  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 0  
Forfeited (in dollars per share) 18.92  
Outstanding at end of period (in dollars per shares) $ 22.88  
Restricted Stock & RSUs    
Restricted Stock & RSUs, PSU    
Outstanding at beginning of period (in shares) 238  
Granted (in shares) 503  
Exercised (in shares) 0  
Vested (in shares) (47)  
Forfeited (in shares) (4)  
Outstanding at end of period (in shares) 690  
Outstanding at beginning of period (in dollars per shares) $ 15.28 17.41
Granted (in dollars per share) 14.83  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 21.35  
Forfeited (in dollars per share) $ 14.84  
PSUs    
Restricted Stock & RSUs, PSU    
Outstanding at beginning of period (in shares) 0  
Granted (in shares) 143  
Exercised (in shares) 0  
Vested (in shares) 0  
Forfeited (in shares) (4)  
Outstanding at end of period (in shares) 139  
Outstanding at beginning of period (in dollars per shares) $ 14.84 $ 0
Granted (in dollars per share) 14.84  
Exercised (in dollars per share) 0  
Vested (in dollars per share) 0  
Forfeited (in dollars per share) $ 14.84  
v3.24.3
Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Income Tax Disclosure [Abstract]        
Effective income tax rate, percent 18.90% 32.40% (74.90%) 30.50%
Capped call transaction termination     $ 1,217  
v3.24.3
Joint Venture Transactions (Details)
$ in Thousands
 1 Months Ended
Apr. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
hotel
Sep. 26, 2024
USD ($)
Hempel and Robinson Park      
Guaranties and environmental indemnity amount     $ 6,200
Lofton Hotel      
Number of guest and suite room | hotel   251  
Payments to acquire equity method investments   $ 5,620  
Equity method investment, ownership percentage   33.30% 24.70%
Proceeds from sale of equity method investments $ 1,500    
Lofton Hotel | The Marcus Corporation      
Equity method investment, ownership percentage sold 8.60%    
v3.24.3
Business Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 26, 2024
Sep. 28, 2023
Sep. 26, 2024
Sep. 28, 2023
Segment Reporting Information [Line Items]        
Revenues $ 232,668 $ 208,766 $ 547,247 $ 568,049
Operating income (loss) 32,782 20,933 18,354 32,755
Depreciation and amortization 17,274 19,158 49,988 51,028
Operating Segments | Theatres        
Segment Reporting Information [Line Items]        
Revenues 143,843 126,585 326,565 359,811
Operating income (loss) 21,761 11,377 18,803 32,707
Depreciation and amortization 11,347 14,258 33,900 37,063
Operating Segments | Hotels/ Resorts        
Segment Reporting Information [Line Items]        
Revenues 88,738 82,098 220,432 207,975
Operating income (loss) 17,041 14,377 17,996 15,450
Depreciation and amortization 5,789 4,817 15,701 13,706
Corporate Items        
Segment Reporting Information [Line Items]        
Revenues 87 83 250 263
Operating income (loss) (6,020) (4,821) (18,445) (15,402)
Depreciation and amortization $ 138 $ 83 $ 387 $ 259
Marcus (NYSE:MCS)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024 Click aqui para mais gráficos Marcus.
Marcus (NYSE:MCS)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024 Click aqui para mais gráficos Marcus.